Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E25.43 EPS (ttm)1.34 Insider Own0.50% Shs Outstand2.53B Perf Week0.53%
Market Cap86.15B Forward P/E17.83 EPS next Y1.91 Insider Trans0.00% Shs Float2.50B Perf Month-2.38%
Income3.39B PEG3.48 EPS next Q0.44 Inst Own14.90% Short Float0.91% Perf Quarter14.42%
Sales22.29B P/S3.86 EPS this Y23.80% Inst Trans0.12% Short Ratio5.19 Perf Half Y25.79%
Book/sh5.13 P/B6.64 EPS next Y2.96% ROA5.40% Target Price34.12 Perf Year11.53%
Cash/sh1.45 P/C23.54 EPS next 5Y7.30% ROE24.90% 52W Range25.55 - 35.60 Perf YTD24.63%
Dividend1.90 P/FCF- EPS past 5Y-17.60% ROI15.00% 52W High-4.35% Beta0.74
Dividend %5.58% Quick Ratio0.60 Sales past 5Y-7.30% Gross Margin82.70% 52W Low33.27% ATR0.54
Employees59700 Current Ratio0.80 Sales Q/Q-11.60% Oper. Margin21.40% RSI (14)52.25 Volatility0.91% 1.46%
OptionableYes Debt/Eq1.34 EPS Q/Q-16.90% Profit Margin15.20% Rel Volume0.82 Prev Close33.89
ShortableYes LT Debt/Eq1.12 EarningsJul 27 BMO Payout33.60% Avg Volume4.38M Price34.05
Recom1.70 SMA200.36% SMA50-0.06% SMA20012.50% Volume3,602,670 Change0.47%
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
Jul-21-17 04:14PM  Biotechs On A Hot Streak, And Could Be 'Cooking With Gas' Investor's Business Daily
08:35AM  Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod Zacks
03:28AM  AstraZeneca CEO reassures staff, aims to be at September cancer meet Reuters
Jul-18-17 08:22AM  5 Big Pharma Stocks With the Best Drug Pipelines Motley Fool
Jul-17-17 06:23PM  CEO departures not always bad for companies: Cramer CNBC Videos
05:47PM  AstraZeneca (AZN) CEO Rumor Reportedly Ends, Shares Rise Zacks
03:11PM  Arena Announces Secondary Stock Worth $150M (revised) Zacks
03:36AM  AstraZeneca Shares Top FTSE 100 After Drugmaker Says CEO Will Host Late-July Earnings Call TheStreet.com
Jul-14-17 09:45PM  Here Are The 5 Stories Europe Was Talking About This Week TheStreet.com
06:19PM  [$$] AstraZeneca CEO's Future Remains Shrouded in Mystery The Wall Street Journal
05:47PM  [$$] Pascal Soriot to remain at AstraZeneca Financial Times
05:43PM  AstraZeneca says CEO Pascal Soriot will host earnings call Reuters
04:55PM  Here are four stocks from the traders to pump up your por... CNBC Videos
04:42PM  AstraZeneca Pops On Report CEO Won't Jump Ship For Teva Pharma Investor's Business Daily
04:05PM  Potential AstraZeneca C-Suite Shuffle Rekindles Takeover Chatter TheStreet.com
03:52PM  AstraZeneca says CEO Pascal Soriot to host call on results Reuters
03:36PM  AstraZeneca Stock Surges After Company Confirms Soriot Staying on as CEO TheStreet.com
03:15PM  AstraZeneca offers no comment after report saying CEO staying Reuters
12:34PM  FTSE 100 knocked back as banks fall, pound surges MarketWatch
12:00PM  This Waltham firm's gonorrhea drug could prevent a global health 'nightmare' American City Business Journals
10:57AM  Pfizer Xeljanz Label Expansion Application Accepted by FDA Zacks
10:41AM  AstraZeneca's silence on CEO wipes out £billions Reuters Videos
10:22AM  J&J (JNJ) Gets FDA Nod for Psoriasis Drug -- Guselkumab Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Mannkind Corporation and AstraZeneca Accesswire
06:13AM  AstraZeneca's silence on CEO helps wipe out 3 billion pounds Reuters
03:44AM  AstraZeneca shares fall for a second day over CEO uncertainty Reuters
12:34AM  [$$] Mystery at AstraZeneca: Is CEO Pascal Soriot Staying or Going? The Wall Street Journal
Jul-13-17 04:15PM  Why AstraZeneca's Rumored Chief Executive Exit Is Bad Timing Investor's Business Daily
04:14PM  Will AstraZeneca's CEO Leave for Teva? Credit Suisse Doesn't Think So TheStreet.com
02:58PM  [$$] AstraZeneca: mystique Financial Times
01:04PM  [$$] AstraZeneca shares hit by report on chief's departure Financial Times
01:01PM  Will AstraZeneca's CEO Leave For Teva? Barrons.com
12:44PM  FTSE 100 slips from 2-week high as AstraZeneca slides MarketWatch
12:42PM  European stocks rise again, building on largest advance in 2½ months MarketWatch
11:45AM  Report: AstraZeneca CEO in running for Teva chief executive job American City Business Journals
11:03AM  Lilly Settles Patent Litigation on Cialis with Generic Firms Zacks
09:37AM  Arrival ceremony for President Trump in France CNBC Videos
07:07AM  AstraZeneca Falls After Report Says Its CEO Is Leaving for Teva Investopedia
06:56AM  AstraZeneca's Unlikely $4 Billion Man Bloomberg
05:11AM  AstraZeneca slumps on report CEO is heading to Teva Reuters
04:53AM  Casino jumps, miners provide support as European shares pause for breath Reuters
03:51AM  AstraZeneca Shares Slump On Reports Teva Courting CEO Pascal Soriot TheStreet.com
Jul-12-17 04:03PM  Teva Stock Jumps as New CEO Expected to Be Named TheStreet.com
03:47PM  AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report Reuters
03:18PM  AstraZeneca's CEO Soriot to join Israeli drugs company Teva-report Reuters
10:13AM  Arena Announces Secondary Stock Offering of 150M Shares Zacks
07:37AM  AstraZeneca Expects Brilinta to Become a Blockbuster Therapy in 2017 Market Realist
Jul-11-17 04:38PM  BioLineRx/Roche Scan BL-8040-Tecentriq for Pancreatic Cancer Zacks
04:00PM  3 Dividend Stocks in Healthcare Motley Fool
03:50PM  3 Large Cap Pharma Stocks to Buy Now Zacks
10:37AM  Bydureon Auto-Injector May Boost the Drugs Sales in Future Years Market Realist
09:44AM  Lilly's Breast Cancer Drug Gets Priority Review Status by FDA Zacks
09:07AM  Farxiga Could See Robust Demand in International Markets in 2017 Market Realist
07:46AM  Sanofi to Buy Vaccine Biotech Protein Sciences for $650M Zacks
07:37AM  Farxiga Expected to Drive AstraZenecas Performance in Diabetes Segment Market Realist
Jul-10-17 03:11PM  Why Myriad Genetics Stock Rocketed 26.3% Higher in June Motley Fool
12:45PM  Performance of AstraZeneca Stock in 2Q17 Market Realist
10:39AM  AstraZeneca Is Focused on Lynparzas Label Expansion in 2017 Market Realist
09:09AM  Lynparza Could Strengthen AstraZenecas Position in Womens Cancer Space Market Realist
07:40AM  Tagrisso Expected to Be a Key Growth Driver for AstraZeneca in 2017 Market Realist
Jul-09-17 09:20PM  What the FDA's Hold on 3 Merck Studies Means for Other Drug Makers TheStreet.com
Jul-07-17 04:42PM  Why Celgene's $413 Million Gamble Helps This Small Biotech More Investor's Business Daily
Jul-06-17 10:32AM  Sanofi Versus AstraZeneca: Large Cap Pharma Stock Faceoff Zacks
Jul-04-17 10:37AM  Johnson & Johnsons Pharmaceuticals Business in 1Q17 Market Realist
09:07AM  Imfinzi May Be AstraZenecas Major Growth Driver Market Realist
07:38AM  AstraZeneca Aims to Offer Multiple Therapies in NSCLC Segment Market Realist
Jul-03-17 03:11PM  3 Top High-Yield Pharmaceutical Stocks to Buy Now Motley Fool
10:39AM  AstraZenecas New Oncology Portfolio May See Healthy Growth Market Realist
09:10AM  AstraZeneca May Witness a Fall in 2017 Net Profit Margin Market Realist
07:41AM  AstraZeneca Expected to Report Fall in Revenues in 2017 Market Realist
Jun-30-17 04:51PM  Analyst Recommendations for AstraZeneca in June 2017 Market Realist
02:54PM  Canada's top court hands patent win to pharmaceutical companies Reuters
09:00AM  Drugmakers Payments to U.K. Health Groups and Doctors Climb 25% Bloomberg
Jun-29-17 04:27PM  AstraZeneca's Cancer Trial Could Help Out A Rival, Analyst Says Investor's Business Daily
09:59AM  Robust 1H for Pharma/Biotech Sector, 3 Big Stocks to Buy Zacks
09:30AM  Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca Zacks
Jun-27-17 10:44AM  AstraZeneca's Faslodex Recommended by CHMP for 1st Line Use Zacks
Jun-23-17 12:09PM  Europe Stocks Slip as Economic Data and Politics Return to the Fore TheStreet.com
Jun-20-17 04:15PM  Could Tesaro Overcome Clovis' Lead On Combos With Merck & Co.? Investor's Business Daily
12:20PM  Label Expansion May Boost Regenerons Dupixent in the Future Market Realist
11:33AM  Biotech Stocks To Watch And Pharma Industry News Investor's Business Daily
11:27AM  5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017 Zacks
11:10AM  Clovis Up Nearly 50% on Solid Data from Ovarian Cancer Study Zacks
08:39AM  4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio Zacks
12:36AM  Can AstraZeneca Thrive on Its Own? Big Test Looms The Wall Street Journal
Jun-19-17 04:55PM  Why This Cancer Drug Specialist Is Up 50% Today Investor's Business Daily
04:38PM  Biotech Flew Nearly 50% On Strong Trial But Is Its Drug Better? Investor's Business Daily
02:21PM  Clovis Oncology's Rubraca Notches Key Trial Win Motley Fool
12:26PM  GSK's new pharma head to join in September after AstraZeneca tussle Reuters
11:45AM  Why Tesaro Inc. Stock Briefly Dipped Today Motley Fool
11:00AM  Why Clovis Oncology Stock Is Soaring Today Motley Fool
08:00AM  [$$] Can AstraZeneca Thrive on Its Own? Big Test Looms The Wall Street Journal
06:00AM  Health Care Stocks Are Crushing the S&P 500 Investopedia
Jun-16-17 04:41PM  Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs? Investor's Business Daily
12:00PM  Europe Benchmarks Rebound as Central Bank Actions Fall by the Wayside TheStreet.com
Jun-15-17 01:08PM  [$$] European takeover rules merit a sceptical response Financial Times
09:08AM  Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug Zacks
Jun-13-17 01:12PM  Regulus, AstraZeneca Cut Ties on Liver Disease Treatment, Shares Dip TheStreet.com
11:51AM  Will Bristol-Myers Share Merck's Woe? Barrons.com
09:18AM  Merck: A Speed Bump For Keytruda? Barrons.com
AstraZeneca PLC engages in the discovery, development, manufacture, and commercialization of prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; strategic collaboration with FibroGen, Astellas, and Pieris Pharmaceuticals Inc; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E5.22 EPS (ttm)7.01 Insider Own0.20% Shs Outstand1.07B Perf Week-1.27%
Market Cap39.00B Forward P/E16.57 EPS next Y2.21 Insider Trans-18.83% Shs Float1.01B Perf Month4.72%
Income7.84B PEG0.68 EPS next Q0.45 Inst Own86.70% Short Float1.63% Perf Quarter13.77%
Sales9.06B P/S4.31 EPS this Y299.00% Inst Trans-0.28% Short Ratio1.85 Perf Half Y19.48%
Book/sh10.71 P/B3.42 EPS next Y10.12% ROA35.10% Target Price36.43 Perf Year22.32%
Cash/sh6.32 P/C5.79 EPS next 5Y7.69% ROE88.30% 52W Range27.28 - 37.48 Perf YTD23.31%
Dividend- P/FCF18.02 EPS past 5Y21.00% ROI30.60% 52W High-2.32% Beta1.36
Dividend %- Quick Ratio1.90 Sales past 5Y-5.10% Gross Margin77.40% 52W Low34.20% ATR0.70
Employees12600 Current Ratio1.90 Sales Q/Q3.70% Oper. Margin24.90% RSI (14)59.54 Volatility1.60% 1.84%
OptionableYes Debt/Eq0.77 EPS Q/Q128.00% Profit Margin86.30% Rel Volume2.49 Prev Close37.18
ShortableYes LT Debt/Eq0.58 EarningsJul 20 AMC Payout0.00% Avg Volume8.91M Price36.61
Recom2.50 SMA202.99% SMA504.63% SMA20013.25% Volume22,216,815 Change-1.53%
Jul-21-17Reiterated Canaccord Genuity Hold $32 → $34
Jul-19-17Reiterated The Benchmark Company Buy $39 → $40
Jul-13-17Reiterated Maxim Group Buy $36 → $40
Jun-27-17Reiterated Aegis Capital Buy $40 → $42
Jun-08-17Reiterated Citigroup Buy $36 → $41
Jun-05-17Upgrade Credit Suisse Neutral → Outperform
Apr-20-17Reiterated Canaccord Genuity Hold $31 → $32
Apr-20-17Downgrade Monness Crespi & Hardt Buy → Neutral
Apr-13-17Reiterated Aegis Capital Buy $38 → $40
Mar-29-17Initiated Barclays Overweight $41
Mar-29-17Initiated Barclays Overweight
Feb-17-17Resumed Pacific Crest Sector Weight
Jan-26-17Reiterated Stifel Hold $31 → $35
Jan-26-17Reiterated RBC Capital Mkts Sector Perform $32 → $34
Jan-26-17Reiterated Aegis Capital Buy $36 → $38
Jan-24-17Reiterated The Benchmark Company Buy $39 → $37
Jan-03-17Resumed Piper Jaffray Neutral $28
Jan-03-17Initiated Aegis Capital Buy $36
Oct-21-16Upgrade Hilliard Lyons Long-term Buy → Buy
Oct-20-16Reiterated Wedbush Neutral $34 → $33
Jul-22-17 03:17PM  Ignore eBay Inc.: Here Are 2 Better Stocks Motley Fool
07:00AM  eBay Inc (EBAY) Stock Is Due for Some Weakness Ahead InvestorPlace
Jul-21-17 06:08PM  Edited Transcript of EBAY earnings conference call or presentation 20-Jul-17 9:00pm GMT Thomson Reuters StreetEvents
05:30PM  What drug-dealing 'darknet' sites have in common with eBay Associated Press
05:19PM  eBay, Inc. Offers a Decent Quarter Motley Fool
04:47PM  eBay Stock Falls to Support After Mediocre Quarter Investopedia
04:35PM  [$$] Visa rallies after benefiting from economic tailwinds Financial Times
04:33PM  EBay Scores Price Target Hikes On Hopes Of Business Acceleration Investor's Business Daily
04:14PM  Here Comes the eBay Plunge TheStreet.com
03:05PM  15 Collectibles That Are Completely Worthless TheStreet.com
01:21PM  StubHub, Classifieds A Drag On eBay's Revenue Forbes
01:04PM  eBay (EBAY) Q2 Earnings Miss Estimates, Revenues Beat Zacks
01:03PM  Dow Is A Drag But These Top Stocks Are Enjoying Big Gains Investor's Business Daily
12:21PM  eBay Slumps on Slower Growth: What About ETFs? Zacks
11:42AM  Story Stocks from Briefing.com Briefing.com
11:38AM  5 Reasons To Remain Buyers Of eBay Benzinga
10:41AM  Trade eBay Inc (EBAY) Stock From the Auction Block InvestorPlace
09:30AM  Vertex Pharma, A10 Networks, Microsoft, Visa and eBay highlighted as Zacks Bull and Bear of the Day Zacks
08:56AM  3 Stocks to Watch on Friday: eBay Inc (EBAY), Visa Inc (V) and Capital One Financial Corp. (COF) InvestorPlace
08:43AM  eBay Earnings Just Arent Enough For Investors 24/7 Wall St.
07:55AM  Baird Shares Two Cents on eBay Inc (EBAY) Following 2Q Results SmarterAnalyst
07:14AM  US STOCKS-Futures slightly lower on earnings from industrial giants Reuters
03:00AM  Ebay Scores Relative Strength Rating Upgrade; Hits Key Threshold Investor's Business Daily
Jul-20-17 09:31PM  EBay meets 2Q profit forecasts Associated Press
08:20PM  Does eBay have a problem? CNBC Videos
06:38PM  EBay Tumbles On Weak Earnings Outlook Investor's Business Daily
05:51PM  eBay Reports Q2 Revenue Beat, GMV Growth of 3% Zacks
05:41PM  After-hours buzz: MSFT, V, EBAY & more CNBC
05:39PM  Microsoft Posts Big Beat, Visa and eBay Also Report Zacks
05:17PM  eBay Meets On Earnings But Slow Growth Disappoints Investors, Shares Down After The Bell Forbes
05:03PM  eBay Stock Drops After-Hours Following 94% Slide in Net Income TheStreet.com
04:43PM  EBay Rattles Investor Faith With Slow Merchandise Growth Bloomberg
04:40PM  EBay announces $3 billion stock buyback program CNBC Videos
04:38PM  eBay reports in line Q2 results ZDNet
04:33PM  eBay lower as Q2 earnings, sales in line with forecast MarketWatch
04:32PM  eBay Off 3%: Q2 Revenue, EPS In-Line, Q3 EPS View Light Barrons.com
04:25PM  Ebay's profit plunges 94 pct Reuters
04:15PM  eBay Inc. Reports Second Quarter 2017 Results PR Newswire
04:12PM  EBay in line with expectations CNBC Videos
03:30PM  3 Stocks That Look Just Like eBay in 1998 Motley Fool
10:35AM  How the Amazon-Whole Foods Deal Could Work against PayPal Market Realist
08:49AM  US STOCKS-Wall St set to open higher on earnings optimism Reuters
08:00AM  [$$] EBay Earnings: What to Watch The Wall Street Journal
Jul-19-17 04:39PM  Two Dow Giants In Buy Range Ahead Of Earnings: Investing Action Plan Investor's Business Daily
12:46PM  EBay Reports Q2 Earnings Tomorrow After Market Close Benzinga
12:24PM  eBay Earnings Preview: Focusing On Replatforming For A Better User Experience Forbes
10:34AM  Unheralded eBay Inc (EBAY) Stock Looks to Add to Big 2017 InvestorPlace
10:14AM  Earnings Preview: What To Expect From Ebay On Thursday Forbes
05:41AM  Shopify Is Turning Another Competitor Into a Partner Motley Fool
Jul-18-17 11:37AM  Beware Fake AMD Ryzen Chips on Amazon, eBay InvestorPlace
11:01AM  The Top Tesla Shareholders (TSLA) Investopedia
Jul-17-17 08:00PM  Major tech firms, internet providers clash over U.S. net neutrality rules Reuters
05:29PM  Chartmaster says these are the 3 names you should buy on ... CNBC Videos
04:25PM  EBay Downgraded When It's in an Uptrend TheStreet.com
02:56PM  Trader tracker: Link adds to eBay & ArcelorMittal CNBC Videos
02:25PM  EBay Downgraded When It's in an Uptrend TheStreet.com
02:18PM  Stocks Cling to Flatline as Wall Street Awaits Earnings TheStreet.com
02:10PM  Nvidia and AMD Might Not Be Riding the Cryptocurrency Mining Wave For Much Longer TheStreet.com
10:27AM  Is a Surprise in Store for eBay (EBAY) this Earnings Season? Zacks
10:00AM  StubHub Releases "17 In 17": Top Bucket List Events To Experience While Traveling Abroad This Summer PR Newswire
09:46AM  The Mercadolibre Genesis Motley Fool
06:00AM  Major tech firms urge U.S. to retain net neutrality rules Reuters
Jul-16-17 12:00PM  3 Things to Watch in the Stock Market This Week Motley Fool
Jul-15-17 08:20AM  [$$] Resellers pounce on Supreme-Louis Vuitton collaboration Financial Times
08:00AM  Week Ahead On Wall Street: Netflix, Microsoft Share Earnings, U.S. Talks Trade With China Forbes
Jul-14-17 08:21PM  6 Things You Didn't Know About PayPal Holdings, Inc. Motley Fool
02:47PM  EBay, Shopify Strike Partnership for New Sales Channel Zacks
11:04AM  Better Buy: eBay Inc vs. Overstock.com, Inc. Motley Fool
10:16AM  A stock market for physical things could change how capitalism works Quartz
09:59AM  Top Analyst Expects Netflix, Inc. (NFLX) to Hand Over a 2Q Beat, eBay Inc (EBAY) Still Challenged by Low Growth SmarterAnalyst
Jul-13-17 07:33PM  eBay Inc. Earnings: What to Watch Motley Fool
04:55PM  Shopify adds eBay as its latest merchant sales channel ZDNet
08:00AM  eBay and Shopify Extend Merchant Reach with New Sales Channel Business Wire
07:12AM  PayPal closes at record high after Apple partnership MarketWatch
01:04AM  Shopify adding eBay as a sales channel for merchants TechCrunch
Jul-12-17 08:15AM  How to work side hustles so you don't lose your day job CNBC
06:26AM  Alibaba Group Holding Ltd.: Buy at the High? Motley Fool
Jul-11-17 01:07PM  Aegis Still Cautious on Snap Inc (SNAP), But Rooting for eBay Inc (EBAY) Ahead of 2Q Print SmarterAnalyst
11:01AM  It's Prime Day, but not all the deals are on Amazon. Here's what others are offering CNBC
10:23AM  EBay: Buy It Now or Wait? TheStreet.com
09:57AM  eBay 'millionaire' sellers in Germany and UK grow 50 percent in four years Reuters
08:41AM  EBay Is A Rare Value Story With Several Paths To Value Creation Benzinga
04:52AM  eBay 'millionaire' sellers in Germany and UK grow 50 pct in 4 years Reuters
Jul-10-17 07:15PM  eBay 'millionaire' sellers in Germany and UK grow 50 pct in 4 years Reuters
02:39PM  A Closer Look At eBay's Focus On Artificial Intelligence Forbes
01:22PM  Prime Day 2017: Amazon's 9 Most Anticipated Deals (And Free Giveaways) Forbes
12:27PM  Buy PayPal Holdings Inc (PYPL) Stock as Digital Payments Gain Steam InvestorPlace
10:33AM  BUYER BEWARE: Fake NES Classic Edition consoles are popping up on eBay Business Insider
Jul-08-17 09:20AM  3 Stocks With eBay-Like Return Potential Motley Fool
09:11AM  MercadoLibre Stock: Everything Investors Need to Know Motley Fool
Jul-07-17 07:35PM  A Quick Glance at Twitters Valuations Market Realist
05:45PM  Technology Stock Roundup: EU Fines Google Shopping Zacks
03:10PM  The big lesson from Photobuckets ransom images debacle Yahoo Finance
01:19PM  Got $5 Million? You Can Now Buy This Flying Car on eBay TheStreet.com
08:49AM  eBay, Inc. breached its 50 day moving average in a Bearish Manner : EBAY-US : July 7, 2017 Capital Cube
06:00AM  eBay Canada Launches Price Match Guarantee PR Newswire
Jul-06-17 10:29AM  eBay Takes its Price Matching Program to United Kingdom Zacks
Jul-05-17 10:35AM  Walmart Marketplace Gaining Serious Traction 24/7 Wall St.
04:00AM  eBay Launches Price Match Guarantee on More Than 20,000 Items in the UK PR Newswire
Jul-04-17 12:47PM  [$$] Former Glencore traders launch metal trading platform Financial Times
eBay Inc. operates commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer their inventory for sale; and buyers to find and purchase it virtually. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com, and the StubHub mobile apps and Ticketbis platforms that connect fans with their favorite sporting events, shows, and artists, as well as enables them to buy and sell tickets. Its Classifieds platforms include a collection of brands, such as mobile.de, Kijiji, Gumtree, Marktplaats, eBay Kleinanzeigen, and others, which offer online classifieds to enable people find whatever they are looking for in their local communities. The company's platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels that include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8930481,815Jul 18 07:28 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,7680107,684Jul 18 07:23 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0018,355064,802Jun 19 09:32 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0018,355064,802Jun 19 09:16 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0023,5130481,363Jun 19 09:13 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0016,750096,481Jun 19 09:11 PM
Schenkel Scott F.Chief Financial OfficerJun 15Option Exercise0.0011,3580108,581Jun 19 09:08 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.006,130099,412Jun 19 09:04 PM
Lawton III Harry ASVP, North AmericaJun 15Option Exercise0.0046,099075,519Jun 19 09:00 PM
Huber Marie OhSVP, GC and SecretaryJun 15Option Exercise0.0033,359070,560Jun 19 08:57 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.0012,551092,651Jun 19 08:54 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.007,845037,076Jun 19 08:52 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.009,861084,011Jun 19 09:40 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 31Option Exercise22.1110,000221,139105,820Jun 02 07:54 PM
FISHER STEPHENSVP, Chief Technology OfficerMay 31Option Exercise21.206,452136,77984,733Jun 02 07:58 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 31Sale34.3235,0001,201,12476,306Jun 02 07:54 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaMay 31Sale34.376,204213,23693,282Jun 02 07:49 PM
FISHER STEPHENSVP, Chief Technology OfficerMay 31Sale34.696,452223,80880,100Jun 02 07:58 PM
SWAN ROBERT HOLMESDirectorMay 25Sale35.0025,000875,000286,562May 26 06:13 PM
Mitic Kathleen C.DirectorMay 18Sale33.8411,897402,56811,456May 22 07:32 PM
Lee Jae HyunSVP, Asia PacificMay 16Sale34.5720,000691,30198,605May 19 05:20 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 12Sale34.112,90399,03030,701May 15 07:25 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 04Sale33.5712,904433,20833,604May 08 06:15 PM
Hammer Bonnie SDirectorApr 27Option Exercise0.008,706012,417May 01 06:20 PM
ANDERSON FRED DDirectorApr 27Option Exercise0.008,706022,683May 01 06:14 PM
TIERNEY THOMAS JDirectorApr 27Option Exercise0.0012,664035,175May 01 05:46 PM
TRAQUINA PERRY MDirectorApr 27Option Exercise0.008,706018,666May 01 05:42 PM
PRESSLER PAUL SDirectorApr 27Option Exercise0.008,706022,916May 01 05:37 PM
BARNHOLT EDWARD WDirectorApr 27Option Exercise0.008,706021,183May 01 05:33 PM
Mitic Kathleen C.DirectorApr 27Option Exercise0.008,706023,353May 01 05:27 PM
SWAN ROBERT HOLMESDirectorApr 27Option Exercise0.008,7060310,961May 01 05:13 PM
Bates Anthony JohnDirectorApr 27Option Exercise0.008,706014,546May 01 05:07 PM
FISHER STEPHENSVP, CTOApr 24Option Exercise21.648,273179,044113,108Apr 26 05:37 PM
FISHER STEPHENSVP, CTOApr 24Sale32.3533,0081,067,91980,100Apr 26 05:37 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0012,4280118,605Apr 04 08:54 PM
Schenkel Scott F.Chief Financial OfficerApr 01Option Exercise0.0019,4930109,778Apr 04 08:36 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168092,294Apr 04 08:29 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,9730106,002Apr 03 08:23 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0012,903058,243Apr 03 08:26 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,323057,174Apr 03 08:30 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0061,3920495,684Apr 03 08:32 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,9190110,533Apr 03 08:36 PM
Huber Marie OhSVP, GC and SecretaryMar 15Option Exercise0.002,501042,811Mar 17 06:51 PM
Todd Jeremy PaulSVP, EMEAMar 15Option Exercise0.002,084076,232Mar 17 06:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMar 15Option Exercise0.004,559033,565Mar 17 06:46 PM
Schenkel Scott F.Chief Financial OfficerMar 15Option Exercise0.006,252093,548Mar 17 06:43 PM
Lawton III Harry ASVP, North AmericaMar 15Option Exercise0.003,647038,350Mar 17 06:41 PM
Lee Jae HyunSVP, Asia PacificMar 15Option Exercise0.003,1260106,177Mar 17 06:38 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMar 15Option Exercise0.005,731098,020Mar 17 06:35 PM
FISHER STEPHENSVP, CTOMar 15Option Exercise0.007,2940103,421Mar 17 06:32 PM
Yetto Kristin ASVP, Chief People OfficerMar 15Option Exercise0.003,126046,972Mar 17 06:29 PM
WENIG DEVINPresident and CEOMar 15Option Exercise0.0013,0860441,121Mar 17 06:26 PM
FISHER STEPHENSVP, CTOMar 01Option Exercise0.0045,8560135,543Mar 03 06:02 PM
Todd Jeremy PaulSVP, EMEAMar 01Option Exercise0.0013,103081,212Mar 03 07:24 PM
Lawton III Harry ASVP, North AmericaMar 01Option Exercise0.0037,870052,390Mar 03 07:12 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMar 01Option Exercise0.0032,7540111,597Mar 03 06:26 PM
Yetto Kristin ASVP, Chief People OfficerMar 01Option Exercise0.0049,538058,198Mar 03 06:48 PM
Lee Jae HyunSVP, Asia PacificMar 01Option Exercise0.0026,2040103,051Mar 03 06:59 PM
Huber Marie OhSVP, GC and SecretaryMar 01Option Exercise0.0037,870040,310Mar 03 07:06 PM
Lee Jae HyunSVP, Asia PaificFeb 27Sale33.986,375216,62976,847Mar 01 05:08 PM
Lawton III Harry ASVP, North AmericaFeb 23Sale33.7313,400451,92214,520Feb 27 07:49 PM
FISHER STEPHENSVP, CTOFeb 22Option Exercise21.6416,543358,02199,657Feb 23 06:33 PM
FISHER STEPHENSVP, CTOFeb 22Sale33.7716,601560,62189,687Feb 23 06:33 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Option Exercise23.0810,974253,27885,966Feb 21 07:40 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Sale33.6630,0101,010,00477,879Feb 21 07:40 PM
Lee Jae HyunSVP, Asia PacificFeb 16Sale34.118,000272,88483,222Feb 21 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerFeb 09Sale33.256,660221,43229,006Feb 10 05:21 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Option Exercise22.6253,1271,201,614117,972Feb 10 05:15 PM
TIERNEY THOMAS JDirectorFeb 08Option Exercise9.856,01459,23828,525Feb 09 07:38 PM
TIERNEY THOMAS JDirectorFeb 08Sale33.286,014200,15722,511Feb 09 07:38 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Sale32.7853,1271,741,57291,222Feb 10 05:15 PM
SWAN ROBERT HOLMESDirectorJan 30Option Exercise22.69125,6082,850,288442,401Jan 31 06:03 PM
SWAN ROBERT HOLMESDirectorJan 30Sale32.00200,6086,418,532301,633Jan 31 06:03 PM
Schenkel Scott F.Chief Financial OfficerDec 15Option Exercise0.006,2520104,017Dec 19 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerDec 15Option Exercise0.00137,6430169,703Dec 19 07:38 PM
Lee Jae HyunSVP, Asia PacificDec 15Option Exercise0.003,126091,222Dec 19 07:32 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0018,487045,313Dec 19 07:28 PM
Lawton III Harry ASVP, North AmericaDec 15Option Exercise0.003,647029,824Dec 19 07:23 PM
Huber Marie OhSVP, GC and SecretaryDec 15Option Exercise0.002,501022,079Dec 19 07:17 PM
Todd Jeremy PaulSVP, EMEADec 15Option Exercise0.002,084069,233Dec 19 07:09 PM
WENIG DEVINPresident and CEODec 15Option Exercise0.0013,0860472,666Dec 16 07:47 PM
FISHER STEPHENSVP, CTODec 15Option Exercise0.007,294093,552Dec 16 07:51 PM
Yetto Kristin ASVP, Chief People OfficerDec 15Option Exercise0.003,126023,966Dec 16 07:57 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Option Exercise22.8818,000411,87644,826Nov 23 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerNov 21Sale28.9318,000520,79626,826Nov 23 07:13 PM
Green LoganDirectorNov 02Buy28.321,00028,3211,000Nov 03 08:02 PM
FISHER STEPHENSVP, CTOOct 25Option Exercise21.6412,408268,532120,563Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 25Sale29.2039,7641,161,10986,258Oct 26 07:50 PM
FISHER STEPHENSVP, CTOOct 15Option Exercise0.00106,5490169,212Oct 17 06:42 PM
Schenkel Scott F.SVP, Chief Financial OfficerOct 15Option Exercise0.005,9070100,848Oct 17 06:37 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980466,832Oct 17 06:32 PM
Yetto Kristin ASVP, Chief People OfficerSep 15Option Exercise0.003,126022,472Sep 19 06:23 PM
Todd Jeremy PaulSVP, EMEASep 15Option Exercise0.002,084068,280Sep 19 06:06 PM
Schenkel Scott F.SVP, Chief Financial OfficerSep 15Option Exercise0.006,252098,204Sep 19 06:00 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerSep 15Option Exercise0.005,731035,051Sep 19 05:54 PM
Lee Jae HyunSVP, Asia PacificSep 15Option Exercise0.003,126088,096Sep 19 05:49 PM
Lawton III Harry ASVP, North AmericaSep 15Option Exercise0.003,647028,081Sep 19 05:44 PM
Huber Marie OhSVP, GC and SecretarySep 15Option Exercise0.002,500020,883Sep 19 05:32 PM
FISHER STEPHENSVP, CTOSep 15Option Exercise0.007,294066,470Sep 19 05:22 PM
Doerger Brian J.VP, Chief Accounting OfficerSep 15Option Exercise0.004,558029,205Sep 19 05:16 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E25.02 EPS (ttm)1.09 Insider Own0.30% Shs Outstand2.11B Perf Week-1.41%
Market Cap57.60B Forward P/E17.57 EPS next Y1.56 Insider Trans0.29% Shs Float1.45B Perf Month5.04%
Income2.60B PEG2.86 EPS next Q0.33 Inst Own37.10% Short Float1.97% Perf Quarter-1.30%
Sales25.34B P/S2.27 EPS this Y-20.90% Inst Trans-0.04% Short Ratio6.21 Perf Half Y-1.90%
Book/sh10.62 P/B2.57 EPS next Y9.97% ROA5.00% Target Price32.74 Perf Year-7.04%
Cash/sh0.03 P/C912.84 EPS next 5Y8.74% ROE11.80% 52W Range24.01 - 30.25 Perf YTD1.04%
Dividend1.68 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-9.69% Beta0.90
Dividend %6.15% Quick Ratio0.50 Sales past 5Y-12.30% Gross Margin13.80% 52W Low13.79% ATR0.38
Employees6800 Current Ratio0.80 Sales Q/Q46.30% Oper. Margin14.60% RSI (14)52.02 Volatility1.18% 1.31%
OptionableYes Debt/Eq1.04 EPS Q/Q9.90% Profit Margin10.30% Rel Volume0.79 Prev Close27.68
ShortableYes LT Debt/Eq0.94 EarningsAug 03 BMO Payout130.50% Avg Volume4.63M Price27.32
Recom1.60 SMA200.86% SMA501.38% SMA2001.03% Volume3,662,285 Change-1.30%
Jun-15-17Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-18-17Initiated Guggenheim Buy
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
Jul-23-17 11:20AM  3 Stocks You Don't Have to Babysit Motley Fool
08:07AM  3 Cheap High-Yield Dividend Stocks You Can Buy Right Now Motley Fool
Jul-21-17 04:10PM  The Best Stock in Texas: Enterprise Product Partners Kiplinger
Jul-20-17 01:12PM  Kinder Morgan Expects a 60% Rise in 2018 Dividends Market Realist
12:14PM  Analyzing Williams Companies Technical Indicators Market Realist
Jul-19-17 04:50PM  Appeals court overturns $535M verdict against Enterprise Products Partners American City Business Journals
02:38PM  Appeals court reverses Energy Transfer's $535M verdict against Enterprise American City Business Journals
09:04AM  Enterprise Products Prevails in Dallas Court of Appeals Business Wire
08:04AM  3 Dividend Stocks That Thrive in Both Bull and Bear Markets Motley Fool
Jul-17-17 02:15PM  MLPs Gained Last Week on Supportive Crude Oil Prices Market Realist
09:23AM  Energy MLPs May Be Best Second Half 2017 Play: 4 to Buy Now 24/7 Wall St.
Jul-14-17 09:12AM  Enterprise Products to Build Ethylene Export Terminal Zacks
Jul-13-17 04:30PM  Why Hertz Global Holdings, Navigator Holdings, and Alder Biopharmaceuticals Jumped Today Motley Fool
02:30PM  Navigator Holdings Ltd. Stock Up 24% on Deal With Enterprise Products: Here's What's Happening Motley Fool
02:05PM  Enterprise Products Partners, London co. plan new ethylene export terminal on Houston Ship Channel American City Business Journals
09:08AM  Kinder Morgans 2Q17 Net Income Is Expected to Be Flat Market Realist
07:39AM  Kinder Morgans 2Q17 Earnings Are Expected to Remain Flat Market Realist
07:38AM  What Williams Companies Current Valuation Tells Us Market Realist
Jul-12-17 06:23PM  Enterprise and Navigator Gas to Develop Ethylene Marine Export Terminal PR Newswire
06:05PM  What Williams Companies Technical Indicators Are Suggesting Market Realist
05:32PM  Enterprise and Navigator Gas to Develop Ethylene Marine Export Terminal Business Wire
Jul-11-17 04:38PM  Enterprise Reschedules Second Quarter Earnings Release and Call Business Wire
11:11AM  Enterprise Products Partners L.P.: The Bear Case From a Bull Motley Fool
07:36AM  A Look at Targa Resources Current Valuation Market Realist
Jul-10-17 05:06PM  EPD, ETP, PAA, WPZ: What Do Current Valuations Indicate? Market Realist
03:13PM  MLPs Were Stable Last Week despite Fall in Crude Oil Prices Market Realist
12:00PM  6 Dividend Stocks Increasing Payouts EPD PNC WSO OZRK TEP TEGP InvestorPlace
Jul-07-17 09:09AM  What MLP Valuations in June Tell Us Now Market Realist
07:40AM  Enterprise Products Hikes Payout, Wins Transportation Deals Zacks
Jul-05-17 06:09PM  3 High-Yield Stocks to Hold Forever Motley Fool
08:30AM  Enterprise Announces Additional Contracts for Midland to ECHO Pipeline System Business Wire
08:00AM  Enterprise Declares Quarterly Distribution Increase Business Wire
Jul-03-17 04:05PM  Energy Transfer Partners and Williams Partners Short Interest Market Realist
03:10PM  ETFs with exposure to Enterprise Products Partners LP : July 3, 2017 Capital Cube
09:09AM  Why Williams Companies Current Valuation Looks Attractive Market Realist
09:09AM  Why BWP Is Bullish on Expansion in Ethane Infrastructure Market Realist
08:34AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : July 3, 2017 Capital Cube
06:51AM  Enterprise to Expand Natural Gas Processing Unit in Texas Zacks
Jul-01-17 12:04PM  2 Reasons Kinder Morgan Inc Is a Better Value Stock Than Enterprise Products Partners L.P. Motley Fool
Jun-30-17 09:09AM  Chart in Focus: Kinder Morgans Valuations Market Realist
Jun-29-17 04:20PM  Enterprise Announces Orla II Natural Gas Processing Plant in West Texas Business Wire
Jun-28-17 04:43PM  3 Stocks With Better Dividends Than Welltower Inc. Motley Fool
11:26AM  Better Buy: Enterprise Products Partners L.P. vs. Williams Partners L.P. Motley Fool
10:29AM  Five Primary Beneficiaries Of Rising U.S. Oil Exports Forbes
Jun-27-17 11:13AM  Why Holly Energy Partners, L.P. Shareholders Have Nothing to Worry About Motley Fool
07:42AM  EPD Is Down 3% Year-to-Date: Whats Next? Market Realist
Jun-23-17 02:48PM  Alerian MLP ETF (AMLP): The Quick Guide to AMLP InvestorPlace
10:33AM  5 Things Enterprise Products Partners' Management Thinks You Should Know Motley Fool
08:00AM  Enterprise Products to Participate in J.P. Morgan Energy Equity Conference Business Wire
Jun-22-17 04:35PM  3 Large-Cap Stocks for Long-Term Investors Motley Fool
12:27PM  In Your 40s? 2 Stocks You Should Consider Buying Motley Fool
Jun-21-17 10:04AM  Enterprise Products to Grow on Fee-Based Deals, Debts High Zacks
Jun-20-17 11:18AM  Enterprise Products Partners L.P.: Buy the Dip? Motley Fool
Jun-19-17 03:17PM  ETFs with exposure to Enterprise Products Partners LP : June 19, 2017 Capital Cube
03:05PM  What Were Key MLP Ratings Updates Last Week? Market Realist
Jun-16-17 10:38AM  Most Analysts Rate Williams Companies A Buy Market Realist
09:07AM  What Williams Companies Current Valuation Suggests Market Realist
Jun-15-17 02:32PM  3 Stocks to Buy With Dividends Yielding More Than 6% Motley Fool
09:15AM  3 Top Stocks for Risk-Averse Investors Motley Fool
08:03AM  Roundtable: 1 Top Stock I'm Excited About Motley Fool
Jun-14-17 10:37AM  Short Interest in Kinder Morgan Fell Market Realist
08:16AM  3 Stocks to Help You Make Money in Retirement Motley Fool
Jun-12-17 06:05PM  The Top MLPs Short Interests Rose Recently Market Realist
02:42PM  MLPs Last Week: PAA, ETP Fell, Oil Prices Fell 4% Market Realist
Jun-09-17 05:20PM  Why Enterprise Products Partners L.P. Is a Dividend Investor's Dream Motley Fool
01:28PM  ETFs with exposure to Enterprise Products Partners LP : June 9, 2017 Capital Cube
Jun-08-17 09:48AM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q1, 2017 By the Numbers : June 8, 2017 Capital Cube
07:36AM  MLPs with Top Upside Potential after May 2017 Market Realist
Jun-07-17 11:09AM  3 High-Yield Dividend Stocks for June Motley Fool
08:07AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : June 7, 2017 Capital Cube
07:37AM  Where Did MLPs Valuations Head during May 2017? Market Realist
Jun-06-17 07:38AM  Short Interest in Energy Transfer Partners Rose Significantly Market Realist
Jun-05-17 04:29PM  How Top MLPs Fared Last Week: EPD, ETP, PAA, and WPZ Market Realist
02:10PM  Here's Why the Best Is Yet to Come for Enterprise Products Partners L.P. Motley Fool
10:30AM  3 Large-Cap Stocks for Astute Investors Motley Fool
08:30AM  Enterprise Products to Participate in Bank of America Merrill Lynch Energy Credit Conference Business Wire
Jun-01-17 07:37AM  What Does Enterprise Products Partners Valuation Indicate? Market Realist
May-31-17 02:58PM  EPDs Largest Pipeline Projects Investopedia
01:35PM  Short Interest in Enterprise Products Partners Fell to 1.4% Market Realist
12:06PM  Enterprise Products Partners Was Stable Last Week Market Realist
10:38AM  Is Williams Companies Relative Valuation Low? Market Realist
10:22AM  Enterprise Products Partners Tracked the MLP Sector Last Week Market Realist
10:13AM  2 Stocks to Buy With Dividends Yielding More Than 6% Motley Fool
May-30-17 05:36PM  Where Energy Transfer Equity Could Wind up Now Market Realist
May-29-17 07:37AM  MLP Valuations Today: How KMI, EPD, PAA, and OKE Compare Market Realist
May-27-17 07:04AM  The 1 Stock I'd Never Put in an IRA Motley Fool
May-26-17 10:36AM  ETE, EPD, KMI, WMB: Analysts Are Bullish on the Midstream Giants Market Realist
09:06AM  ETE, EPD, KMI, and WMB: What the Current Valuations Indicate Market Realist
08:29AM  Enterprise Products Partners LP breached its 50 day moving average in a Bearish Manner : EPD-US : May 26, 2017 Capital Cube
07:35AM  Are Institutional Investors Bullish on EPD, ETE, KMI, and WMB? Market Realist
May-25-17 09:06AM  ETE, EPD, KMI, and WMB: A Leverage Comparison after 1Q17 Market Realist
08:52AM  Enterprise Products to Participate in Annual MLPA Investor Conference Business Wire
07:35AM  Analyzing Energy Transfer Equitys High Leverage Market Realist
May-24-17 10:36AM  Energy Transfer Equity Had $43 Billion in Debt at the End of 1Q17 Market Realist
09:49AM  My 3 Biggest Stock Holdings Motley Fool
09:06AM  KMI, WMB Expect Higher Capital Spending in 2017 Market Realist
07:36AM  What Enterprise Products Could Offer Income Investors Market Realist
May-23-17 12:00PM  3 Top-Notch High-Yield Stocks to Buy Right Now Motley Fool
10:38AM  ETE, EPD, KMI, and WMB: Analyzing Earnings Growth in 2017 Market Realist
09:08AM  Analyzing Revenue Growth of ETE, EPD, KMI, and WMB in 2017 Market Realist
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,670 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas and ethane export terminals, and related operations. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 440 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,120 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 686 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates approximately 4,250 miles of refined products pipelines; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Edwin EAdvisory DirectorMar 06Sale28.0215,000420,300420,654Mar 06 05:18 PM
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-4.04 Insider Own2.30% Shs Outstand342.74M Perf Week1.51%
Market Cap6.00B Forward P/E4.59 EPS next Y3.81 Insider Trans-65.64% Shs Float337.62M Perf Month27.92%
Income-1407.30M PEG- EPS next Q0.95 Inst Own66.80% Short Float10.11% Perf Quarter105.64%
Sales9.41B P/S0.64 EPS this Y-714.90% Inst Trans20.57% Short Ratio1.44 Perf Half Y18.81%
Book/sh11.13 P/B1.57 EPS next Y6.27% ROA-3.10% Target Price- Perf Year-28.51%
Cash/sh3.53 P/C4.96 EPS next 5Y-7.26% ROE-34.10% 52W Range8.31 - 32.74 Perf YTD20.52%
Dividend- P/FCF3.74 EPS past 5Y61.43% ROI-1.60% 52W High-46.56% Beta-0.37
Dividend %- Quick Ratio1.00 Sales past 5Y31.90% Gross Margin72.60% 52W Low110.57% ATR0.67
Employees21500 Current Ratio1.30 Sales Q/Q-11.10% Oper. Margin-5.20% RSI (14)65.45 Volatility2.90% 4.73%
OptionableYes Debt/Eq7.33 EPS Q/Q265.40% Profit Margin-15.00% Rel Volume0.43 Prev Close17.60
ShortableYes LT Debt/Eq7.24 EarningsAug 08 BMO Payout- Avg Volume23.64M Price17.50
Recom3.00 SMA203.59% SMA5020.42% SMA20018.23% Volume10,081,524 Change-0.57%
Jun-16-17Initiated Cantor Fitzgerald Overweight $18
May-10-17Reiterated RBC Capital Mkts Sector Perform $18 → $19
Apr-20-17Reiterated JP Morgan Neutral $15 → $10
Mar-23-17Reiterated RBC Capital Mkts Sector Perform $21 → $18
Mar-06-17Reiterated Rodman & Renshaw Neutral $23 → $17
Feb-27-17Reiterated Mizuho Underperform $11 → $9
Feb-14-17Reiterated RBC Capital Mkts Sector Perform $29 → $22
Feb-10-17Reiterated Barclays Equal Weight $34 → $20
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Aug-15-16Upgrade Mizuho Underperform → Neutral $11 → $25
Jul-21-17 09:38AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Back From the Abyss InvestorPlace
06:00AM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences Motley Fool
Jul-20-17 04:24PM  Sequoia Fund Seen Bouncing Back After Valeant Saga GuruFocus.com
Jul-19-17 02:03PM  Valeant Just Showed Why Its Share Price Has Deservedly Fallen by 93% Since August 2015 Motley Fool
11:37AM  When Should Investors Buy Options? Motley Fool
10:54AM  Valeant Pharmaceuticals Intl Inc (VRX) In Good Debt Shape, Vertex Pharmaceuticals Incorporated (VRTX) Wows with Triple CF Combo Success SmarterAnalyst
10:16AM  Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt Zacks
07:10AM  Featured Company News - Valeant Pharma Divests its Skin Care Business, Obagi Medical Products Business Accesswire
Jul-18-17 09:30AM  The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics Zacks
08:23AM  Street Talk: Tesla Inc (TSLA), Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) SmarterAnalyst
08:00AM  Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Impax Laboratories Accesswire
07:13AM  Valeant is meeting its debt goals, but core business is still struggling MarketWatch
06:00AM  The Unreformed Stock Picker: Without A Boss Bill Miller Is Betting On Amazon, Bitcoin And Bob Dylan Forbes
Jul-17-17 06:20PM  Valeant Takes Haircut on 2013 Obagi Deal as Debt Pile Looms, Divestitures Continue TheStreet.com
04:12PM  M&A Monday: Church & Dwight, Dominion Diamond, Valeant & More Investor's Business Daily
03:38PM  Pershing Square Sells $610 Million of Restaurant Brands, Stock Drops 2% Investopedia
11:41AM  Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back InvestorPlace
11:30AM  Valeant Unloads Yet Another Unit Barrons.com
09:30AM  Stocks to Watch: Procter & Gamble, Blue Apron, Netflix, Citigroup, BlackRock The Wall Street Journal
09:26AM  4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings Zacks
07:08AM  Valeant agrees to sell Obagi Medical Products for $190 million in cash MarketWatch
07:00AM  Valeant Agrees To Sell Obagi Medical Products Business CNW Group
05:57AM  Biotech Scoop: Valeant Pharmaceuticals Intl Inc (VRX), Teva Pharmaceutical (TEVA), and Kite Pharma (KITE) SmarterAnalyst
Jul-14-17 12:24PM  Valeant Suffers Another Blow After the Approval of Johnson & Johnson's Psoriasis Treatment TheStreet.com
09:35AM  J&J Psoriasis Drug Approval 'Another Negative' For Valeant Barrons.com
08:22AM  Valeant Pharmaceuticals Overall Trajectory Remains on Edge, Teva Pharmaceutical May Face Difficulty Beating Consensus SmarterAnalyst
Jul-13-17 06:33PM  Valeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March Higher TheStreet.com
12:56PM  Valeant Pharmaceuticals Intl Inc (VRX) Pays Off Further Debt, Apple Inc. (AAPL) iPhone 8 Delay Rumors Swirl SmarterAnalyst
10:26AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is No Longer a Sewer InvestorPlace
10:04AM  Stocks to Watch: Snap, Target, Macy's, Delta, American Airlines, Valeant The Wall Street Journal
08:42AM  Valeant redeems $500 million of debt, on track to meet or exceed $5 billion debt reduction goal MarketWatch
08:30AM  Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018 PR Newswire
08:30AM  Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018 CNW Group
Jul-12-17 12:09PM  Valeant's Valuation 'Does Not Make Sense,' Warns Piper Jaffray Barrons.com
08:44AM  Has Valeant Pharmaceuticals Intl Inc (VRX) Stock Finally Bottomed? InvestorPlace
07:50AM  Featured Company News - Valeant Pharma Pays Off $811 Million in Terms Loans Accesswire
Jul-10-17 05:00PM  Valeant Announces Q2 2017 Financial Results Date And Conference Call Details PR Newswire
04:54PM  Valeant Continues Quest to Repay Massive $30 Billion Debt Load, Shares Close Higher TheStreet.com
11:52AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Seeing a Lot of Quiet Buying InvestorPlace
07:08AM  Valeant pays down $811 million of term loans, shares rise MarketWatch
07:00AM  Valeant Pays Down $811 Million of Senior Secured Term Loans PR Newswire
Jul-07-17 09:43AM  4 Big Reasons Valeant Pharmaceuticals Skyrocketed 44% in June Motley Fool
08:00AM  Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Celsion Corporation Accesswire
Jul-06-17 11:13AM  Do Valeant Fundamentals Justify The Decrease In Bearish Sentiment? Benzinga
11:02AM  Valeant: A Long Road Ahead? Barrons.com
09:01AM  John Paulson Is Truly a Glutton for Punishment Motley Fool
07:00AM  Bausch + Lomb Japan Launches Bausch + Lomb AQUALOX® Contact Lenses PR Newswire
Jul-05-17 01:00PM  Why Chesapeake Energy Corporation (CHK) Stock Isnt Coming Back Soon InvestorPlace
Jun-30-17 09:06AM  The Market In 5 Minutes Benzinga
07:57AM  [$$] Valeant After Ackman: Paulson Logs 26% Gain Barrons.com
07:00AM  Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International CNW Group
Jun-29-17 10:12PM  Sanpower's SVP Says Dendreon Deal Is a Milestone Bloomberg Video
05:13PM  Valeant Pharma Continues Asset Sales Instead of 'Riskier' Debt Swaps TheStreet.com
04:17PM  Benzinga's Option Alert Recap From June 29 Benzinga
02:00PM  Vulnerable Drugmakers Can't Shrug Off the FDA Bloomberg
12:01PM  3 Big Stock Charts for Thursday: Merck & Co., Inc. (MRK), Gilead Sciences, Inc. (GILD) and Valeant Pharmaceuticals Intl Inc (VRX) InvestorPlace
11:14AM  5 Reasons Valeant Can Keep Flying Barrons.com
10:49AM  Valeant's (VRX) NDA for Bowel Cleansing Drug Accepted by FDA Zacks
10:28AM  Top 3 Companies Owned by Valeant (VRX) Investopedia
10:01AM  Valeant's Chart Is Actually Looking Pretty Good For A Change Benzinga
09:52AM  Valeant Could be Worth 30% More If It Can Continue to Execute Turnaround Efforts TheStreet.com
09:07AM  Your first trade for Thursday, June 29 CNBC
08:59AM  Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Untouchable InvestorPlace
08:50AM  Valeant Investors: Cantor Says It's Time To Stop Waiting For The Other Shoe To Drop Benzinga
08:37AM  Sanpower Group Completes the Acquisition of Dendreon from Valeant PR Newswire
08:31AM  Morning Movers: Constellation Brands Jumps, Sarepta Climbs, Valeant Gains Barrons.com
07:00AM  Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group PR Newswire
07:00AM  Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group CNW Group
Jun-28-17 06:00PM  Salix Announces Filing Acceptance for PLENVU®* Next Generation Bowel Cleansing Preparation for Colonoscopies PR Newswire
05:59PM  "Fast Money" final trades: TBT, VRX, and more CNBC Videos
05:45PM  Cantor Boosts Price Target for Valeant Pharmaceuticals Intl Inc; Heres Why SmarterAnalyst
05:15PM  Paulson Dives Deeper Into Valeant With Increased Holding GuruFocus.com
04:50PM  Will Valeants Lenders Have to Take a Haircut Through Debt-Equity Swap? SmarterAnalyst
05:47AM  Valeant Most Exposed With FDA Generics Push Investopedia
Jun-27-17 02:02PM  Valeant: Out of the Frying Pan, Into the Fire Barrons.com
10:27AM  Go Long Valeant Pharmaceuticals Intl Inc (VRX) Stock Even After This Rip InvestorPlace
09:51AM  Bill Ackman's Big Triumph Becomes His Big Problem Bloomberg
09:49AM  Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday TheStreet.com
08:33AM  Are Options Traders Betting on a Big Move in Valeant Pharmaceuticals (VRX) Stock? Zacks
Jun-26-17 09:32PM  Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers TheStreet.com +8.10%
05:28PM  Valeant: Paulson & Co. Puts (a Bit More) Money Where its Mouth is Barrons.com
05:27PM  Hedge fund Paulson & Co discloses 6.3 percent stake in Valeant Reuters
04:55PM  Paulson Boosts His Stake in Valeant Pharmaceuticals to 6.3% Bloomberg
04:38PM  Biden tells Ackman never disrespect memory of his dead son MarketWatch
04:31PM  Why Rite Aid, Valeant Pharmaceuticals, and Hertz Global Holdings Jumped Today Motley Fool
04:24PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Could Have 30% Upside InvestorPlace
02:17PM  Valeant Pharma: A Debt Swap? Barrons.com
01:08PM  3 Cheap Healthcare Stocks You Can Buy Right Now Motley Fool
11:29AM  Billionaire Ackman Could Win Big on Blackstone's Platform Buy Investopedia
11:02AM  CANADA STOCKS-TSX down as softer commodity prices weigh on resource shares Reuters
Jun-23-17 04:02PM  Paulson Times Appointment to Valeant's Board Perfectly Motley Fool
11:54AM  Nvidia Corporation (NVDA) Stock Is Too Hot. Buy This Instead. InvestorPlace
09:06AM  What Bill Miller Thinks about Valeant Now Market Realist
Jun-22-17 04:40PM  Why Barnes & Noble, SunPower, and Valeant Pharmaceuticals Jumped Today Motley Fool +13.30%
12:08PM  Hospitals Rise on Senate Health Bill But Long-Term Prognosis in Question Barrons.com
11:38AM  Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case? InvestorPlace
08:01AM  Donald Trump Softens Stance on Drug Prices, Sends Biotech Stocks Soaring Motley Fool
07:30AM  Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International PR Newswire
07:30AM  Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International CNW Group
Jun-21-17 02:11PM  Mizuho Expects Valeant Pharmaceuticals Intl Inc (VRX) Shares to Drift Lower, Pacific Crest Cheers Amazon.com, Inc.s (AMZN) New Prime Wardrobe Service SmarterAnalyst
Valeant Pharmaceuticals International, Inc. operates as a pharmaceutical and medical device company worldwide. It operates in three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The company offers Lotemax gel for the treatment of inflammation and pain following ocular surgery; Ocuvite, a lutein eye vitamin and mineral supplement; PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus products; Biotrue multi-purpose solution for healthy contact lens wear; Artelac to treat dry eyes; Boston, a cleansing solution for gas permeable contact lenses; and Bedoyecta, a vitamin B complex. It also provides SofLens daily disposable contact lenses; ophthalmic surgical products; PureVision, a silicone hydrogel; Biotrue ONEday daily disposable contact lenses; Bausch + Lomb Ultra, a silicone hydrogel replacement contact lens; and medical device systems. In addition, the company offers Xifaxan for the treatment of irritable bowel syndrome; Provenge for the treatment of prostate cancer; Uceris to get ulcerative colitis under control; Arestin, a subgingival sustained-release antibiotic; Jublia for the treatment of onychomycosis; Solodyn for the treatment of acne; Elidel to treat skin conditions; and Glumetza tablets to enhance glycemic control. Further, it provides Wellbutrin XL for the treatment of major depressive disorder; Isuprel injections; Xenazine for the treatment of chorea; Nitropress for the reduction of blood pressure of patients in hypertensive crises; Cuprimine to treat Wilson's disease; Zegerid to treat certain stomach and esophagus problems; Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; and Latanoprost medicines to treat a type of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DE SCHUTTER RICHARD UDirectorMay 11Buy13.9020,000278,00070,572May 15 05:19 PM
DE SCHUTTER RICHARD UDirectorMar 15Buy10.8010,000108,00025,190Mar 16 05:12 PM
Herendeen PaulEVP and CFOMar 14Buy10.7224,000257,280174,000Mar 16 05:04 PM
ValueAct Holdings, L.P.DirectorMar 14Buy10.823,000,00032,465,00016,937,431Mar 16 04:31 PM
Pershing Square Capital ManageDirectorMar 13Sale11.0018,114,432199,258,7520Mar 14 04:14 PM
Ross Thomas W. Sr.DirectorDec 14Buy14.735,00073,65026,822Dec 16 04:19 PM
Pershing Square Capital ManageDirectorDec 12Sale14.853,476,69051,628,84718,114,432Dec 13 04:14 PM
KARABELAS ARGERIS NDirectorAug 11Buy24.654,00098,60020,726Aug 12 04:37 PM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E9.95 EPS (ttm)8.73 Insider Own0.20% Shs Outstand400.98M Perf Week1.16%
Market Cap34.83B Forward P/E9.60 EPS next Y9.05 Insider Trans-85.19% Shs Float324.26M Perf Month9.17%
Income3.62B PEG- EPS next Q2.69 Inst Own76.60% Short Float3.49% Perf Quarter1.70%
Sales30.87B P/S1.13 EPS this Y-4.70% Inst Trans0.15% Short Ratio4.08 Perf Half Y-4.42%
Book/sh16.03 P/B5.42 EPS next Y-7.34% ROA15.30% Target Price94.70 Perf Year9.84%
Cash/sh4.14 P/C20.97 EPS next 5Y-2.78% ROE57.90% 52W Range71.55 - 97.64 Perf YTD1.27%
Dividend3.60 P/FCF25.24 EPS past 5Y16.00% ROI24.60% 52W High-11.03% Beta1.04
Dividend %4.14% Quick Ratio1.30 Sales past 5Y-9.50% Gross Margin19.00% 52W Low21.41% ATR1.42
Employees13000 Current Ratio2.20 Sales Q/Q25.00% Oper. Margin15.90% RSI (14)66.58 Volatility1.40% 1.58%
OptionableYes Debt/Eq1.40 EPS Q/Q-15.90% Profit Margin11.70% Rel Volume0.78 Prev Close87.02
ShortableYes LT Debt/Eq1.30 EarningsJul 28 BMO Payout39.10% Avg Volume2.77M Price86.87
Recom2.70 SMA203.32% SMA505.78% SMA2000.99% Volume2,152,177 Change-0.17%
Jun-26-17Initiated HSBC Securities Buy $101
May-08-17Downgrade BofA/Merrill Buy → Underperform
Feb-10-17Downgrade Susquehanna Positive → Neutral
Feb-06-17Reiterated RBC Capital Mkts Sector Perform $92 → $95
Dec-29-16Reiterated Cowen Market Perform $87 → $90
Oct-14-16Initiated Tudor Pickering Buy
Sep-13-16Reiterated Deutsche Bank Hold $80 → $83
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Jul-21-17 09:30AM  LyondellBasell gives final green light to $2.4B chemical plant in Houston area American City Business Journals
06:30AM  LyondellBasell to Build the World's Largest PO/TBA Plant in Texas PR Newswire
Jul-20-17 10:49AM  Is Surprise in the Cards for Materials ETFs in Q2 Earnings? Zacks
Jul-18-17 10:37AM  Whos LyondellBasell Cooking up a License Deal with Now? Market Realist
Jul-14-17 08:14AM  LyondellBasell to Discuss Second-Quarter Results on Friday, July 28, 2017 PR Newswire
Jul-10-17 09:06AM  Why Eastman Chemical Is Trading at a Premium to Its Peers Market Realist
Jul-03-17 12:59PM  LyondellBasell to Provide Specialized Training to Cologne Firefighters PR Newswire
Jun-29-17 03:44PM  LyondellBasell Industries NV Value Analysis (NYSE:LYB) : June 29, 2017 Capital Cube
09:07AM  Why LyondellBasell Is Trading at a Discount to Peers Market Realist
07:40AM  What Wall Street Analysts Recommend for LyondellBasell Market Realist
Jun-28-17 12:35PM  Is LyondellBasell Managing Its Interest Expenses Efficiently? Market Realist
11:05AM  LyondellBasells Debt Is on the Rise Market Realist
09:15AM  Is a Turnaround in the Cards for LyondellBasell? Market Realist
08:26AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : June 28, 2017 Capital Cube
Jun-26-17 11:18AM  Will Pandora Shares Soar to $16 -- or Plummet to $3.50? TheStreet.com
Jun-14-17 01:40PM  ETFs with exposure to LyondellBasell Industries NV : June 14, 2017 Capital Cube
Jun-02-17 12:16PM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : June 05th, 2017 (record date) : By the numbers : June 2, 2017 Capital Cube
May-30-17 12:33PM  ETFs with exposure to LyondellBasell Industries NV : May 30, 2017 Capital Cube
08:24AM  LyondellBasell Announces New Share Repurchase Program Market Realist
May-29-17 09:07AM  What Analysts Recommend for LyondellBasell Market Realist
08:12AM  LyondellBasell Hikes Dividend, Gets Nod for Share Repurchase Zacks
07:38AM  How LyondellBasells Dividend Yield Has Changed Market Realist
03:55AM  LyondellBasell (LYB) Down 7.7% Since Earnings Report: Can It Rebound? Zacks
May-26-17 05:22PM  LyondellBasell Pleases Investors with Dividend Increase Market Realist
May-24-17 06:45AM  LyondellBasell Announces Increase to Quarterly Dividend and Shareholder Approval of New Share Repurchase Program PR Newswire
May-23-17 09:00AM  LyondellBasell to Address Bernstein 33rd Annual Strategic Decisions Conference PR Newswire
May-22-17 05:39PM  LyondellBasell to Build Hyperzone Polyethylene Plant Market Realist
12:42PM  LyondellBasell Receives Five Top Safety Awards PR Newswire
May-16-17 04:10PM  LyondellBasell starts construction on Gulf Coast plant using new technology American City Business Journals
03:12PM  LyondellBasell to Address Barclays Americas Select Franchise Conference 2017 PR Newswire
09:22AM  LyondellBasell Starts Construction of New Plant at La Porte Zacks
May-15-17 05:01PM  LyondellBasell Begins Construction of Hyperzone PE Plant at its La Porte Complex PR Newswire
04:03PM  ETFs with exposure to LyondellBasell Industries NV : May 15, 2017 Capital Cube
May-08-17 10:21AM  Material ETFs Rise on Solid Q1 Earnings Zacks
09:07AM  Top Analyst Upgrades and Downgrades: Asure Software, Fluor, Lam Research, Newfield Exploration, Tesla, Yext and Many More 24/7 Wall St.
May-04-17 04:08PM  ETFs with exposure to LyondellBasell Industries NV : May 4, 2017 Capital Cube
May-03-17 10:11AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017 Capital Cube
10:03AM  LyondellBasell Among Top Donors to United Way of Greater Houston Campaign for 2016 PR Newswire
May-02-17 01:00PM  [$$] Chemical industry split about the case for more US plants Financial Times
10:36AM  Dow Chemicals Latest Valuations Post 1Q17 Earnings Market Realist
08:20AM  Edited Transcript of LYB earnings conference call or presentation 28-Apr-17 3:00pm GMT Thomson Reuters StreetEvents
Apr-28-17 03:31PM  LyondellBasell (LYB) Misses Q1 Earnings Estimates, Sales Top Zacks
07:55AM  LyondellBasell (LYB) Q1 Earnings Miss Estimates, Sales Beat Zacks
06:56AM  LyondellBasell misses 1Q profit forecasts Associated Press
06:45AM  LyondellBasell Reports First-Quarter 2017 Earnings PR Newswire
Apr-26-17 04:50PM  LyondellBasell (LYB) Q1 Earnings: What's in the Cards? Zacks
Apr-21-17 08:28PM  [$$] Judge Dismisses Most of Lyondell Bankruptcy Lawsuit The Wall Street Journal
08:27PM  [$$] Blavatnik cleared of fraud claims over Lyondell Chemical buyout Financial Times
10:50AM  What's in Store for Material ETFs in Q1 Earnings? Zacks
09:06AM  What Are Dow Chemicals Valuations ahead of 1Q17 Earnings? Market Realist
Apr-20-17 09:07AM  Why DuPont Trades at a Premium to Its Peers Market Realist
Apr-17-17 09:49AM  LyondellBasells ACP Polyethylene Technology to Be Used by Hengli Market Realist
Apr-14-17 11:30AM  LyondellBasell to Discuss First-Quarter Results on Friday, April 28, 2017 PR Newswire
Apr-05-17 09:29AM  Opening Bell, April 5, 2107 CNBC Videos
09:29AM  Opening Bell, April 5, 2107
Apr-03-17 11:20AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : March 06th, 2017 (record date) : By the numbers : April 3, 2017 Capital Cube
11:20AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : March 06th, 2017 (record date) : By the numbers : April 3, 2017
09:55AM  LyondellBasell Joins the Astros Foundation Community Leaders Program PR Newswire
Mar-31-17 08:55AM  See which Houston brands rank among the 500 most valuable in the U.S. this year at bizjournals.com
Mar-30-17 09:30AM  Zacks Industry Outlook Highlights: Dow Chemical, DuPont, PPG Industries, Celanese and LyondellBasell Industries Investopedia
09:30AM  Zacks Industry Outlook Highlights: Dow Chemical, DuPont, PPG Industries, Celanese and LyondellBasell Industries
09:07AM  Inside Eastman Chemicals Latest Valuations Market Realist
09:07AM  Inside Eastman Chemicals Latest Valuations
Mar-29-17 03:46PM  Chemicals Industry Stock Outlook - March 2017 Investopedia
03:46PM  Chemicals Industry Stock Outlook - March 2017
01:04PM  LyondellBasell to Host Investor Day 2017 on April 5, 2017 PR Newswire
10:00AM  Is LyondellBasell (LYB) a Great Stock for Value Investors? Zacks
10:00AM  Is LyondellBasell (LYB) a Great Stock for Value Investors?
10:00AM  Is LyondellBasell (LYB) a Great Stock for Value Investors? at Investopedia
Mar-23-17 07:37AM  Dow Chemical Trades at a Premium to Its Peers Market Realist
07:37AM  Dow Chemical Trades at a Premium to Its Peers
Mar-22-17 12:35PM  Dow Chemical Provides a Stable Dividend Yield
10:51AM  Dow Chemical Will Pay a Dividend of $0.46 in 1Q17
10:50AM  Analyzing How Dow Chemical Stock Has Performed in 2017
Mar-20-17 10:05AM  Shandong Yuhuang Shengshi Chemical Finalizes Deal with LYB
09:07AM  What Huntsmans Inconsistent Dividend Means to Investors
Mar-13-17 09:07AM  Can LyondellBasells Valuation Come Out of Its Peers Shadow?
07:37AM  LyondellBasell Gets Hold Rating from Majority of Analysts
Mar-10-17 01:05PM  How Attractive Is LyondellBasells Dividend Yield?
11:35AM  LyondellBasell Gears Up to Pay Its First Dividend in 2017
09:48AM  LyondellBasell Stock: 2017 Performance So Far
09:00AM  LyondellBasell Honored by Junior Achievement with US President's Volunteer Service Award PR Newswire
07:35AM  LyondellBasell (LYB) Poised on Expansion Amid Challenges
Mar-09-17 12:46PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
Mar-07-17 11:35AM  LyondellBasells Interest Expenses Set to Fall Further
10:05AM  What LyondellBasells Debt-to-Equity Ratio Indicates
08:20AM  LyondellBasell Issued $1 Billion of Guaranteed Notes
Feb-28-17 01:06PM  LyondellBasell Prices $1 Billion in Public Offering Guaranteed Notes
Feb-27-17 09:07AM  Why DuPont Is Trading at a Premium Compared to Its Peers
Feb-23-17 05:26PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials
Feb-21-17 05:51PM  LyondellBasell Prices Public Offering of Guaranteed Notes PR Newswire
10:33AM  LYB International Finance II B.V. -- Moody's rates LyondellBasell's new notes Baa1, outlook stable at Moody's
Feb-17-17 01:05PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 10-K, Annual Report
06:45AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Feb-14-17 08:15AM  Post Earnings Coverage as LyondellBasell's Q4 Top-line Beat Market Estimates Accesswire
Feb-08-17 09:06AM  How Are Analysts Viewing LyondellBasell after 4Q16 Earnings?
07:36AM  Why LyondellBasells Refining Segment Revenues Rose in 4Q16
Feb-07-17 02:19PM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
10:40AM  Why Did LYBs Intermediates and Derivatives Segments Revenue Rise?
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers worldwide. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; polyolefins, such as polyethylene and polypropylene (PP); and PP homopolymers, copolymers, and compounds. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, methanol products, glacial acetic acids, vinyl acetate monomers, and ethylene oxides and derivatives. In addition, it refines crude oil into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts, as well as purchases and sells ethylene. The company also exports its products. LyondellBasell Industries N.V. was founded in 2005 and is based in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roudeix RichardSVP, O&P - EAIMay 01Option Exercise40.002329,2805,086May 03 03:29 PM
AI New Holdings 2 LLC10% OwnerMar 09Sale89.12139,61712,441,96972,772Mar 10 04:12 PM
AI New Holdings 2 LLC10% OwnerMar 02Sale93.5039,4253,686,23872,912Mar 03 04:48 PM
AI New Holdings 2 LLC10% OwnerMar 01Sale94.32206,78719,504,43972,951Mar 03 04:48 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Option Exercise78.2714,7691,155,95931,283Feb 22 08:13 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Sale94.0114,7691,388,41616,514Feb 22 08:13 PM
AI New Holdings 2 LLC10% OwnerFeb 22Sale94.5514,1711,339,85873,157Feb 24 04:04 PM
AI New Holdings 2 LLC10% OwnerFeb 13Sale92.24862,20579,532,80773,171Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 10Sale92.45305,70028,261,84374,030Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 09Sale92.29900,00083,056,95074,334Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 08Sale91.591,132,095103,689,48775,231Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 07Sale93.021,000,00093,018,14776,359Feb 09 06:11 PM
Bindra Jagjeet S.DirectorAug 30Sale80.013,750300,0208,876Sep 01 09:17 AM
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E33.20 EPS (ttm)5.49 Insider Own0.20% Shs Outstand391.00M Perf Week0.68%
Market Cap71.23B Forward P/E17.90 EPS next Y10.18 Insider Trans-9.82% Shs Float390.47M Perf Month3.75%
Income2.17B PEG3.06 EPS next Q2.27 Inst Own89.70% Short Float0.54% Perf Quarter17.51%
Sales18.74B P/S3.80 EPS this Y3.50% Inst Trans0.05% Short Ratio1.47 Perf Half Y26.95%
Book/sh55.74 P/B3.27 EPS next Y10.23% ROA4.80% Target Price188.07 Perf Year16.63%
Cash/sh1.85 P/C98.27 EPS next 5Y10.85% ROE10.10% 52W Range139.07 - 182.77 Perf YTD29.11%
Dividend0.60 P/FCF29.56 EPS past 5Y13.90% ROI6.40% 52W High-0.32% Beta1.07
Dividend %0.33% Quick Ratio0.90 Sales past 5Y9.60% Gross Margin45.90% 52W Low31.00% ATR1.97
Employees55000 Current Ratio1.40 Sales Q/Q10.90% Oper. Margin13.60% RSI (14)70.32 Volatility1.01% 1.12%
OptionableYes Debt/Eq0.78 EPS Q/Q38.70% Profit Margin11.60% Rel Volume0.55 Prev Close181.55
ShortableYes LT Debt/Eq0.70 EarningsJul 26 BMO Payout10.90% Avg Volume1.43M Price182.18
Recom1.70 SMA202.84% SMA504.07% SMA20015.63% Volume786,736 Change0.35%
Jul-20-17Upgrade Cleveland Research Neutral → Buy
May-19-17Initiated Cantor Fitzgerald Overweight $194
May-09-17Reiterated Barclays Overweight $175 → $190
Jan-18-17Initiated Deutsche Bank Buy $163
Nov-10-16Resumed Leerink Partners Outperform
Sep-22-16Resumed JP Morgan Overweight $180
Sep-09-16Downgrade Cleveland Research Buy → Neutral
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Jul-21-17 09:16AM  Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock? Zacks
Jul-18-17 05:00PM  Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes PR Newswire
09:06AM  Will Thermo Fisher's (TMO) Q2 Earnings Surpass Expectations? Zacks
08:34AM  Thermo Fisher Scientific (Finance I) B.V. -- Moody's assigns Baa2 to Thermo Fisher's EUR bonds; outlook stable Moody's
Jul-17-17 04:15PM  Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock? Zacks
Jul-13-17 04:44PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : July 13, 2017 Capital Cube
09:07AM  TMOs Recent Developments in the Small Molecule Research Field Market Realist
07:38AM  TMOs Oncomine Target Test Launch Will Boost This Business Market Realist
Jul-12-17 05:35PM  Thermo Fisher Scientific Accelerates Its Semiconductor Sequencing Market Realist
04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend PR Newswire
03:57PM  Most Analysts Recommend Buys on Thermo Fisher Scientific Market Realist
11:13AM  5 Top Nanotechnology Stocks to Buy Motley Fool
Jul-10-17 10:13AM  Thermo Fisher at a 52-Week High: What's Driving the Stock? Zacks
Jul-03-17 08:00AM  Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2017 PR Newswire
Jun-30-17 03:28PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : June 30, 2017 Capital Cube
01:44PM  Why the US is losing the war on drug prices: trader Yahoo Finance
Jun-27-17 10:31AM  Thermo Fisher Gets FDA's PMA for Oncomine Dx Target Test Zacks
Jun-26-17 08:15AM  Featured Company News - Thermo Fisher's Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA Accesswire
Jun-22-17 09:57AM  Why Hold Strategy is Apt for Thermo Fisher (TMO) Stock Now Zacks
Jun-20-17 03:19PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : June 20, 2017 Capital Cube
Jun-19-17 11:55AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
09:08AM  How Strykers Margins Are Driven by Its CTG Program Market Realist
Jun-15-17 11:09AM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : June 15th, 2017 (record date) : By the numbers : June 15, 2017 Capital Cube
Jun-13-17 11:56AM  PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria TheStreet.com
Jun-09-17 08:20AM  Earnings up at Patheon ahead of acquisition by Thermo Fisher American City Business Journals
Jun-05-17 09:06AM  Behind Thermo Fishers Recent Stock Performance Market Realist
08:00AM  Thermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ASMS 2017 PR Newswire
07:36AM  Thermo Fisher on the Street: Inside the Analyst Recommendations Market Realist
Jun-02-17 10:36AM  Understanding Thermo Fishers Capital Deployment Strategy Market Realist
09:06AM  What Does Thermo Fisher Want in the Clinical Mass Spectrometry Business? Market Realist
07:36AM  Inside Thermo Fishers Key Partnerships in Diagnostics Market Realist
Jun-01-17 10:37AM  Understanding Thermo Fishers Growth Strategy Market Realist
09:08AM  How Long Can Thermo Fisher Scientifics Asia-Pacific Growth Momentum Last? Market Realist
07:38AM  Thermo Fishers Next Big Deal in the Medical Device Industry Market Realist
May-31-17 05:35PM  Heres What Keeps Boosting Thermo Fishers Growth Market Realist
04:42PM  3 Top Gene-Sequencing Stocks Poised for Solid Growth Motley Fool
03:42PM  Key Highlights from Thermo Fishers 1Q17 Earnings Market Realist
May-30-17 08:26AM  Thermo Fisher on an Acquisition Spree, Competition Rife Zacks
07:20AM  Why Is Thermo Fisher (TMO) Up 3.7% Since the Last Earnings Report? Zacks
May-26-17 07:37AM  St. Jude Medical May Establish ABT as a Key Medical Device Player Market Realist
May-25-17 03:54PM  Analysts Recommendations for Abbott Laboratories in May 2017 Market Realist
May-19-17 07:16PM  Phononic CEO shares the key to his company's market penet... CNBC Videos
10:19AM  Thermo Fisher Initiated With 'Overweight' Rating at Cantor Fitzgerald TheStreet.com
May-18-17 02:23PM  Royal DSM N.V. -- Moody's changes Royal DSM's outlook to stable from negative; affirms A3/P-2 ratings Moody's
08:30AM  Thermo Fisher Scientific Declares Quarterly Dividend PR Newswire
May-17-17 03:46PM  Patheon Holdings I B.V. -- Moody's places ratings of Patheon Holdings I B.V. on review for upgrade Moody's
May-16-17 12:23PM  Thermo Fisher Scientific (Finance I) B.V. -- Moody's affirms Thermo Fisher Scientific's Baa2 senior unsecured rating following Patheon acquisition announcement Moody's
10:12AM  Company News for May 16, 2017 Zacks
08:33AM  Thermo Fisher (TMO) to Buy Patheon, Expand in Biopharma Zacks
08:15AM  Blog Coverage: Thermo Fisher to Acquire Patheon; Expects to Realize Multiple Synergies from the Transaction Accesswire
May-15-17 04:11PM  Thermo Fisher Scientific: A Growth Story (TMO) Investopedia
04:07PM  Patheon Stock Spikes After Being Purchased by Thermo Fisher for $7.2 Billion TheStreet.com
01:31PM  [$$] Thermo Fisher to Buy Patheon for $5.2 Billion The Wall Street Journal
01:26PM  Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services Reuters
12:47PM  Some of Wall Street's biggest firms just landed a big pay day Business Insider
11:58AM  Did Pantheon Get Enough in Its Buyout? 24/7 Wall St.
11:19AM  US STOCKS-S&P 500, Nasdaq Composite hit record-highs Reuters
11:05AM  Why Patheon N.V. Is Soaring Today Motley Fool
10:55AM  Thermo Fisher buys Patheon Reuters Videos
10:40AM  Waltham's Thermo Fisher buys drug ingredients maker for $5.2B American City Business Journals
10:03AM  Story Stocks from Briefing.com Briefing.com
08:43AM  DSM to tender Patheon stake to Thermo Fisher Reuters
07:53AM  Thermo Fisher buying Patheon for $5.2 billion Associated Press
07:45AM  Thermo Fischer to Buy Patheon in $7.2 Billion Deal Bloomberg Video
07:37AM  Stock Futures Mostly Higher as Russia, Saudi Arabia Call for OPEC Deal Extension TheStreet.com
07:34AM  Thermo Fisher to buy Patheon for about $5.2 bln Reuters
07:27AM  Thermo Fisher Scientific is buying drug-ingredients maker Patheon for $7.2 billion Business Insider
07:20AM  5 Things You Must Know Before the Market Opens Monday TheStreet.com
07:19AM  Thermo Fisher to acquire Patheon in deal valued at $7.2 billion, including $2 billion net debt MarketWatch
07:18AM  DSM Informs Market on Patheon N.V. PR Newswire
07:14AM  Thermo Fisher to buy Patheon for about $5.2 bln Reuters
07:14AM  Thermo Fisher to buy Patheon in $5.2 billion deal CNBC
07:00AM  Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO) PR Newswire
12:03AM  Thermo Fisher in talks to buy Patheon: Bloomberg Reuters
May-14-17 11:45PM  Thermo Fisher in talks to buy Patheon - Bloomberg Reuters
10:49PM  Thermo Fisher Said in Talks to Buy Drug Ingredient Maker Patheon Bloomberg
10:49PM  Thermo Fisher Extends Buying Binge With Talks to Acquire Patheon Bloomberg
May-09-17 06:48PM  Cramer's lightning round: This telecom's quarter was less than impressive CNBC
07:30AM  Cramer: These Sectors Look Bullish (Part III) TheStreet.com
May-08-17 11:20AM  How to Get on Board Thermo Fisher Scientific TheStreet.com
May-05-17 10:35AM  3 Sexy Stocks And One For Downside Protection Forbes
08:00AM  Thermo Fisher Scientific to Host Analyst Meeting PR Newswire
May-01-17 08:15AM  Post Earnings Coverage as Thermo Fisher's Quarterly Revenue Grew 11%; GAAP EPS Surged 39% Accesswire
Apr-27-17 09:41PM  Edited Transcript of TMO earnings conference call or presentation 26-Apr-17 12:30pm GMT Thomson Reuters StreetEvents
Apr-26-17 05:27PM  Edwards Lifesciencse and Deckers rise; US Steel plunges Associated Press +5.79%
04:41PM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : April 26, 2017 Capital Cube
04:19PM  GLOBAL MARKETS-Stocks retreat after Trump tax plan; Canada dollar, Mexico peso weaken Reuters
01:50PM  GLOBAL MARKETS-Stocks advance on earnings; Canada dollar, Mexico peso weaken on NAFTA news Reuters
10:46AM  Thermo Fisher (TMO) Tops Q1 Earnings, Sales, Raises Guidance Zacks
07:53AM  Thermo Fisher (TMO) Beats on Q1 Earnings & Sales Estimates Zacks
06:21AM  Thermo Fisher tops profit estimate, ups forecast Reuters
06:14AM  Thermo Fisher beats Street 1Q forecasts Associated Press
06:00AM  Thermo Fisher Scientific Reports First Quarter 2017 Results PR Newswire
Apr-25-17 09:03AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : April 25, 2017 Capital Cube
Apr-21-17 07:05AM  Thermo Fisher (TMO) Up 4.5% Since Earnings Report: Can It Continue? Zacks
Apr-20-17 04:20PM  The Top Gene-Sequencing Stock to Buy in 2017 Motley Fool
10:01AM  Will Thermo Fisher (TMO) Pull a Surprise in Q1 Earnings? Zacks
Apr-18-17 06:00AM  New X-ray Machine Handles Heavy Products in Washdown Environments PR Newswire
Apr-05-17 05:35PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : April 5, 2017 Capital Cube
11:18AM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : March 15th, 2017 (record date) : By the numbers : April 5, 2017 Capital Cube
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers controlled temperature technology products; sample preparation and preservation equipment; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; and research and safety market channel, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williamson StephenSr. VP and CFOJun 05Sale176.262,500440,65037,790Jun 06 04:36 PM
CASPER MARC NChief Executive OfficerJun 01Sale172.7920,0003,455,800269,279Jun 02 04:36 PM
Shine Daniel PSenior Vice PresidentMay 24Option Exercise65.154,688305,42329,200May 25 05:29 PM
Shine Daniel PSenior Vice PresidentMay 24Sale171.884,688805,75024,512May 25 05:29 PM
Loewald Thomas WSenior Vice PresidentApr 27Sale168.761,532258,54041,277Apr 28 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 15Sale160.739,0791,459,26862,517Mar 16 05:11 PM
CASPER MARC NChief Executive OfficerMar 15Sale158.6020,0003,172,000289,279Mar 16 05:07 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 10Option Exercise126.229,9871,260,56081,583Mar 13 05:14 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 10Sale158.189,9871,579,74471,596Mar 13 05:14 PM
Loewald Thomas WSenior Vice PresidentMar 08Option Exercise73.247,675562,11750,484Mar 09 04:13 PM
Loewald Thomas WSenior Vice PresidentMar 08Sale157.397,6751,207,96842,809Mar 09 04:13 PM
Williamson StephenSr. VP and CFOMar 06Sale158.712,500396,77540,290Mar 08 05:15 PM
Loewald Thomas WSenior Vice PresidentMar 06Sale158.714,049642,61742,809Mar 08 05:12 PM
HOOGASIAN SETH HSr. VP and Gen. CounselMar 06Sale158.713,142498,66731,104Mar 08 05:10 PM
CASPER MARC NChief Executive OfficerSep 02Option Exercise54.9728,7971,582,971307,444Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 02Sale151.0128,7974,348,635278,647Sep 06 04:52 PM
CASPER MARC NChief Executive OfficerSep 01Option Exercise54.9730,0001,649,100308,647Sep 02 05:32 PM
CASPER MARC NChief Executive OfficerSep 01Sale151.1730,0004,535,076278,647Sep 02 05:32 PM
Shine Daniel PSenior Vice PresidentAug 29Sale152.281,699258,72417,437Aug 31 05:00 PM
Loewald Thomas WSenior Vice PresidentAug 29Sale152.283,256495,82435,814Aug 31 04:58 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 29Sale152.282,270345,67627,384Aug 31 04:56 PM
Shine Daniel PSenior Vice PresidentAug 26Sale151.7847672,24719,136Aug 30 05:20 PM
Loewald Thomas WSenior Vice PresidentAug 26Sale151.92913138,70339,070Aug 30 05:17 PM
CASPER MARC NChief Executive OfficerAug 15Sale155.9625,0003,899,031295,998Aug 17 04:54 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 10Sale156.005,023783,58831,914Aug 11 04:46 PM
HARRIS C MARTINDirectorAug 05Sale157.3339061,3594,648Aug 08 04:53 PM
CRM Salesforce.com, inc. daily Stock Chart
CRM [NYSE]
Salesforce.com, inc.
IndexS&P 500 P/E472.05 EPS (ttm)0.19 Insider Own0.10% Shs Outstand708.80M Perf Week-0.34%
Market Cap63.57B Forward P/E53.26 EPS next Y1.68 Insider Trans-80.13% Shs Float675.34M Perf Month2.43%
Income131.70M PEG16.65 EPS next Q0.32 Inst Own87.50% Short Float2.72% Perf Quarter7.04%
Sales8.86B P/S7.17 EPS this Y457.90% Inst Trans0.08% Short Ratio4.05 Perf Half Y17.97%
Book/sh11.24 P/B7.98 EPS next Y29.74% ROA0.80% Target Price101.79 Perf Year9.78%
Cash/sh4.54 P/C19.75 EPS next 5Y28.34% ROE1.90% 52W Range66.43 - 91.99 Perf YTD31.01%
Dividend- P/FCF35.25 EPS past 5Y69.50% ROI2.10% 52W High-2.50% Beta1.29
Dividend %- Quick Ratio0.70 Sales past 5Y29.90% Gross Margin73.10% 52W Low35.01% ATR1.37
Employees25000 Current Ratio0.70 Sales Q/Q24.60% Oper. Margin0.00% RSI (14)55.49 Volatility1.21% 1.56%
OptionableYes Debt/Eq0.32 EPS Q/Q-123.10% Profit Margin1.50% Rel Volume0.64 Prev Close90.54
ShortableYes LT Debt/Eq0.18 EarningsAug 17 AMC Payout0.00% Avg Volume4.54M Price89.69
Recom1.80 SMA201.45% SMA501.17% SMA20011.45% Volume2,928,398 Change-0.94%
Jun-27-17Initiated SunTrust Buy $110
May-19-17Reiterated Stifel Buy $100 → $105
May-15-17Reiterated The Benchmark Company Buy $100 → $110
May-15-17Reiterated BMO Capital Markets Outperform $92 → $100
Apr-27-17Initiated Credit Suisse Outperform $110
Mar-01-17Reiterated Wedbush Outperform $98 → $102
Feb-28-17Resumed Robert W. Baird Outperform $90
Feb-16-17Initiated Needham Hold
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $105 → $76
Jan-11-17Initiated Wells Fargo Outperform
Nov-18-16Reiterated Wedbush Outperform $96 → $98
Nov-18-16Reiterated Mizuho Buy $85 → $95
Nov-18-16Reiterated BMO Capital Markets Outperform $86 → $90
Oct-18-16Initiated Rosenblatt Buy $90
Sep-01-16Reiterated Wedbush Outperform $98 → $96
Sep-01-16Reiterated RBC Capital Mkts Outperform $91 → $85
Sep-01-16Reiterated Mizuho Buy $100 → $85
Sep-01-16Reiterated BMO Capital Markets Outperform $98 → $86
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
Jul-21-17 01:07PM  Denver auditor finds possible security issues with city's 311 system American City Business Journals
12:58PM  How LinkedIn May (or May Not) Pay Off for Microsoft Fortune
11:02AM  Microsoft Corporation (MSFT) Stock Is Value You Can Bank On InvestorPlace
10:26AM  Microsoft's Reincarnation & The Cloud Revolution Investopedia
09:58AM  Merrill Lynch Out With Six Top Software Stocks To Buy For Rest Of 2017 24/7 Wall St.
Jul-20-17 08:13PM  Microsoft Office 365 Just Hit a Big Milestone Fortune
07:44PM  These 3 Tech Leaders Are Within 2% Of Buy Points: Google, Broadcom, Salesforce Investor's Business Daily
08:59AM  Microsoft Corporation (MSFT) Stock Is Pricey, But Poised to Pounce InvestorPlace
08:00AM  U.S. Bank Brings Intelligence to Commercial Banking with Salesforce Einstein PR Newswire
08:00AM  Salesforce Positioned in the Leaders Quadrant of the 2017 Magic Quadrant for Sales Force Automation for Eleventh Consecutive Year PR Newswire
03:49AM  Cloud services lift SAP sales but costs tether profit growth Reuters
02:47AM  Salesforce bridges gap between development worlds ZDNet
01:08AM  SAP quarterly profit shy of forecast on higher cloud costs Reuters
Jul-19-17 05:00PM  Trading tech ahead of earnings: 5 picks CNBC Videos
Jul-17-17 04:08PM  These 5 Tech Superstars Are Setting Up Near Buy Points Investor's Business Daily
11:17AM  SFMTA director says naming site Salesforce Transit Center is 'distasteful' American City Business Journals
11:08AM  When Software Mergers Heat Up, These Companies Will Be Buyers Investor's Business Daily
10:09AM  Tableau Software Returns To Bank Of America's Top Picks List Benzinga
Jul-16-17 07:43AM  5 Things You Probably Didn't Know About Veeva Systems Inc. Motley Fool
Jul-14-17 03:57PM  Salesforce will get to slap its name on San Francisco's new transit center and some folks are not happy about it Business Insider
02:05PM  This chart shows just how volatile the fight for IT dominance could be over the next 3 years for everyone but Microsoft Business Insider
01:44PM  ETFs with exposure to salesforce.com, inc. : July 14, 2017 Capital Cube
01:39PM  These Stocks Could Profit From Artificial Intelligence: Analyst Investor's Business Daily
12:21PM  Why Salesforce, Splunk, Microsoft and Other Software Stocks Could Rip Even Higher TheStreet.com
09:19AM  Salesforce CEO Marc Benioff Recruits Axed Microsoft Employees on Twitter Fortune
07:10AM  Featured Company News Salesforce.com Delivers Einstein AI and Analytics for Field Service Lightning Accesswire
Jul-13-17 08:04PM  Salesforce CEO Marc Benioff has a message for laid-off Microsoft workers: Work for me Business Insider
04:55PM  Salesforces Chief Equality Officer: Heres How You Promote Diversity at Work Fortune
08:26AM  Salesforce (CRM) to Go Live On Amazon Web Services In Canada Zacks
Jul-12-17 04:24PM  Microsoft Debuts AI Unit to Take on Tricky Questions Fortune
09:05AM  Salesforce brings digital transformation to field workers with AI, analytics tools TechRepublic
08:48AM  Workday Wants to Enlist More Outside Software Developers Fortune
08:01AM  Salesforce Now Live on Amazon Web Services Cloud Infrastructure in Canada PR Newswire
08:00AM  Salesforce rolls out new AI-powered tools for mobile workers ZDNet
08:00AM  Salesforce Is Now Live From Amazons Canadian Cloud Fortune
08:00AM  Salesforce Delivers Einstein AI and Analytics For Field Service Lightning PR Newswire
06:25AM  Investors Should Keep Their Heads in the Cloud: Cramer's 'Off the Charts' TheStreet.com
Jul-11-17 07:12PM  Cramer's charts show 3 cloud stocks shooting for the star... CNBC Videos
06:59PM  Cramer's charts show 3 cloud stocks shooting for the stars CNBC
08:41AM  salesforce.com, inc. breached its 50 day moving average in a Bullish Manner : CRM-US : July 11, 2017 Capital Cube
Jul-06-17 04:30PM  Salesforce Executive to Participate in Upcoming Investor Event PR Newswire
Jul-03-17 04:15PM  Salesforce Chairman and CEO Marc Benioff to Keynote Salesforce Trailhead Live Tokyo PR Newswire
12:28PM  Bite Apple Inc. (AAPL) Stock In Spite of Bland Leadership InvestorPlace
Jul-02-17 07:24AM  3 Reasons to Still Buy Veeva Systems Stock After Its Huge Gains This Year Motley Fool
Jun-30-17 07:00AM  Tech: A Tectonic Shift Toward Enterprise Cloud Computing Morningstar
Jun-29-17 05:36PM  General Motors Adds Fleet Productivity Service to OnStar The Wall Street Journal
03:31PM  salesforce.com, inc. Value Analysis (NYSE:CRM) : June 29, 2017 Capital Cube
11:27AM  Nvidia Corporation (NVDA) Stock Is a Buy on This Correction InvestorPlace
Jun-28-17 03:39PM  Salesforce's newest 'Einstein' AI tools can tell when people are mad in texts and emails Business Insider
10:53AM  Has IBM Watsons AI Technology Fallen Victim to Hype? Fortune
09:23AM  salesforce.com, inc. breached its 50 day moving average in a Bearish Manner : CRM-US : June 28, 2017 Capital Cube
08:00AM  Today's Research Reports on Stocks to Watch: Salesforce and FireEye Accesswire
08:00AM  Salesforce steps up developer efforts for Einstein ZDNet
08:00AM  Salesforce Maps a New Path Forward for Developer Success--Empowering Everyone to Build Smart Apps on the World's #1 CRM Platform PR Newswire
Jun-27-17 08:17PM  Which Member of This Artificial Intelligence Partnership Is Getting the Better Deal? Motley Fool
06:06PM  Salesforce, Hubspot and Other 'Verbs' That Are Cloud Winners, Per SunTrust Barrons.com
01:23PM  Top tech manager: buy this stock CNBC Videos
12:28PM  Salesforce stock has potential to double: Josh Spencer CNBC Videos
10:37AM  Salesforce Is a Silent Assassin That Investors Would Be Foolish to Ignore TheStreet.com
09:10AM  Microsoft and Box Ink Yet Another Cloud Partnership Fortune
09:00AM  New $100 Million Fund Backs Cloudflare-Related Startups Fortune
08:11AM  It Sounds Crazy, But Workday Is Cheap Motley Fool
08:01AM  Some FANG stocks are still undervalued, says Salesforce CEO Marc Benioff CNBC
08:00AM  Salesforce Chairman and CEO Marc Benioff to Participate in the World Economic Forum Annual Meeting of the New Champions 2017 PR Newswire
Jun-26-17 10:51AM  3 Growth Stocks for Conservative Investors Motley Fool
Jun-24-17 01:47PM  Where Are The Early Investing Hot Spots In Artificial Intelligence? Investor's Business Daily
12:01AM  [$$] Oracle Conquers the Cloud, and Just in Time Barrons.com
Jun-23-17 04:17PM  As Oracle's Cloud Business Grows, Ellison Throws Verbal Jabs at Rival Salesforce TheStreet.com
Jun-22-17 11:56AM  Five9 CEO: Plenty of Opportunity, and Yes, We Could Get Bought Barrons.com
11:16AM  Oracle CEO: Our strategy is about suite of application of... CNBC Videos
10:50AM  Silicon Valley's corporate-campus building boom is a cautionary tale MarketWatch
07:56AM  Oracle leaps to record as cloud transition hits turning point MarketWatch
12:14AM  Oracle Surges 10%: Well On Our Way to Passing Salesforce, Says Ellison Barrons.com
Jun-21-17 01:12PM  Yahoo Finance Live: Midday Movers - Jun 21st, 2017 Yahoo Finance Video
09:45AM  Persistent Systems and Attivio Announce Engage 360 on the Salesforce AppExchange, the World's Leading Enterprise Apps Marketplace PR Newswire
08:00AM  Salesforce Has Been Selected by Airbus to Put Customers at the Center of its Business PR Newswire
06:00AM  Goldman Sachs: Stock Picks for a New Era Investopedia
05:00AM  Why Cant Your Company Just Fix the Gender Wage Gap? Bloomberg
Jun-20-17 01:30PM  This Salesforce Ally Is Gearing Up to Take on Microsoft and Oracle Fortune
11:13AM  Adobe Unveils Advertising Cloud TV Integrated with Analytics Zacks
10:33AM  Why Oracle Corporation (ORCL) Stock Is Looking as Sharp as Ever InvestorPlace
Jun-19-17 06:05PM  Oracles New API Platform: What to Expect Market Realist
05:57PM  Silicon Valley giants that would benefit from Kushner tech reforms to government Yahoo Finance
06:55AM  [$$] Tech M&A: thrift shop picks Financial Times
04:20AM  Salesforce (CRM) Down 2% Since Earnings Report: Can It Rebound? Zacks
Jun-16-17 06:00PM  Salesforce Positioned by Gartner in the Leaders Quadrant of the 2017 Magic Quadrant for Mobile Application Development Platforms, Worldwide PR Newswire
10:21AM  3 Opportunities Twilio Inc. Bears Need to Know About Motley Fool
Jun-15-17 01:54PM  How Salesforce Gained Its Moat Market Realist
01:36PM  ETFs with exposure to salesforce.com, inc. : June 15, 2017 Capital Cube
09:45AM  Four marketing technology lessons via Salesforce's State of Marketing report ZDNet
09:14AM  Salesforce to use AI to boost your sales, marketing, and customer service efforts TechRepublic
08:00AM  Salesforce Launches Einstein Analytics: Advanced Analytics Powered By AI on the World's #1 CRM Platform PR Newswire
08:00AM  Salesforce launches Einstein Analytics, Discovery, aims to bring AI to business users ZDNet
07:55AM  Salesforce Extends Health Cloud Beyond the Doctor's Office and Allows Care Teams to Collaborate Across Multiple Patient Plans PR Newswire
Jun-14-17 08:00PM  AI will create 800,000 jobs and $1.1 trillion revenue by 2021: Salesforce ZDNet
08:00AM  A Trillion-Dollar Boost: Salesforce Releases New Research on the Economic Impact of Artificial Intelligence on CRM PR Newswire
Jun-13-17 07:00PM  Who else but Trump to call for a nation full of apprentices? Associated Press
06:15PM  Why These 4 Tech Stocks May Beat Apple, Facebook Investopedia
11:25AM  Technology Stocks: Do They All Deserve to Fall? Investopedia
09:04AM  salesforce.com, inc. breached its 50 day moving average in a Bearish Manner : CRM-US : June 13, 2017 Capital Cube
Salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices, as well as solutions for partner relationship management. It also provides Service Cloud, which enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud to plan, personalize, and optimize one-to-one customer interactions. In addition, the company offers Commerce Cloud to deliver a digital commerce experience; Community Cloud to create and manage branded digital destinations for customers, partners, and employees; Internet of Things Cloud that provides insights to companies enabling them to sell, service, and market to their customers in personalized ways, as well as engage with them in real time; and Analytics Cloud that enables employees across an organization to explore business data, uncover new insights, make decisions, and take action from various devices. Further, it provides Salesforce Quip, a next-generation productivity solution for teams with a mobile-first strategy to collaborate without email; and Salesforce Platform for building enterprise apps. Additionally, the company offers professional cloud services, such as consulting, deployment, training, user-centric design, and integration to facilitate the adoption of its solutions; and architects and innovation program teams, as well as various education services comprising introductory online courses and advanced architecture certifications. Salesforce.com, inc. offers its services through direct sales; and through consulting firms, systems integrators, and other partners. The company was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board and CEOJul 20Option Exercise39.0910,000390,92534,195,300Jul 20 07:34 PM
Benioff MarcChairman of the Board and CEOJul 20Sale90.2310,000902,30634,185,300Jul 20 07:34 PM
Roos John VictorDirectorJul 20Sale89.6922820,44916,132Jul 20 07:38 PM
Benioff MarcChairman of the Board and CEOJul 19Option Exercise39.0910,000390,92534,195,300Jul 19 07:36 PM
Benioff MarcChairman of the Board and CEOJul 19Sale89.4610,000894,56634,185,300Jul 19 07:36 PM
Benioff MarcChairman of the Board and CEOJul 18Option Exercise39.0910,000390,92534,195,300Jul 18 07:53 PM
Harris ParkerCo-FounderJul 18Option Exercise39.098,027313,79549,913Jul 18 08:02 PM
Benioff MarcChairman of the Board and CEOJul 18Sale89.1510,000891,53434,185,300Jul 18 07:53 PM
Harris ParkerCo-FounderJul 18Sale89.178,027715,74741,886Jul 18 08:02 PM
Benioff MarcChairman of the Board and CEOJul 17Option Exercise39.0910,000390,92534,195,300Jul 18 07:53 PM
Benioff MarcChairman of the Board and CEOJul 17Sale89.6410,000896,36234,185,300Jul 18 07:53 PM
Conway CraigDirectorJul 17Sale90.1725022,5439,352Jul 18 07:55 PM
Benioff MarcChairman of the Board and CEOJul 14Option Exercise39.0910,000390,92534,195,300Jul 18 07:53 PM
Benioff MarcChairman of the Board and CEOJul 14Sale89.9510,000899,47534,185,300Jul 18 07:53 PM
Benioff MarcChairman of the Board and CEOJul 13Option Exercise39.0910,000390,92534,195,300Jul 13 07:14 PM
Roos John VictorDirectorJul 13Sale90.5022820,63416,360Jul 13 07:11 PM
Benioff MarcChairman of the Board and CEOJul 13Sale89.9410,000899,39834,185,300Jul 13 07:14 PM
Benioff MarcChairman of the Board and CEOJul 12Option Exercise39.0910,000390,92534,195,300Jul 12 09:00 PM
Benioff MarcChairman of the Board and CEOJul 12Sale89.9210,000899,22434,185,300Jul 12 09:00 PM
Benioff MarcChairman of the Board and CEOJul 11Option Exercise39.0910,000390,92534,195,300Jul 12 09:00 PM
Harris ParkerCo-FounderJul 11Option Exercise39.098,027313,79549,913Jul 12 06:42 PM
Benioff MarcChairman of the Board and CEOJul 11Sale88.2210,000882,16234,185,300Jul 12 09:00 PM
Harris ParkerCo-FounderJul 11Sale88.228,027708,12141,886Jul 12 06:42 PM
Benioff MarcChairman of the Board and CEOJul 10Option Exercise39.0910,000390,92534,195,300Jul 10 07:55 PM
Benioff MarcChairman of the Board and CEOJul 10Sale88.3010,000883,03534,185,300Jul 10 07:55 PM
Benioff MarcChairman of the Board and CEOJul 07Option Exercise39.0910,000390,92534,195,300Jul 07 07:41 PM
Benioff MarcChairman of the Board and CEOJul 07Sale87.9610,000879,64334,185,300Jul 07 07:41 PM
Benioff MarcChairman of the Board and CEOJul 06Option Exercise39.0910,000390,92534,195,300Jul 06 07:14 PM
Benioff MarcChairman of the Board and CEOJul 06Sale86.9010,000868,98234,185,300Jul 06 07:14 PM
Roos John VictorDirectorJul 06Sale86.6222819,74916,588Jul 06 07:19 PM
Benioff MarcChairman of the Board and CEOJul 05Option Exercise39.0910,000390,92534,195,300Jul 05 08:27 PM
Harris ParkerCo-FounderJul 05Option Exercise39.098,027313,79549,913Jul 05 08:34 PM
Benioff MarcChairman of the Board and CEOJul 05Sale87.1210,000871,19534,185,300Jul 05 08:27 PM
Harris ParkerCo-FounderJul 05Sale87.128,027699,28541,886Jul 05 08:34 PM
Benioff MarcChairman of the Board and CEOJul 03Option Exercise39.0910,000390,92534,195,300Jul 05 08:27 PM
Benioff MarcChairman of the Board and CEOJul 03Sale86.0010,000859,97434,185,300Jul 05 08:27 PM
Weaver Amy EPres., Legal & General CounselJul 03Sale87.041,400121,85616,513Jul 05 08:30 PM
Benioff MarcChairman of the Board and CEOJun 30Option Exercise39.0910,000390,92534,195,300Jul 05 08:27 PM
Benioff MarcChairman of the Board and CEOJun 30Sale86.9010,000868,97934,185,300Jul 05 08:27 PM
BLOCK KEITHPres., Vice Chairman and COOJun 29Option Exercise37.9510,000379,50010,000Jun 29 07:34 PM
Benioff MarcChairman of the Board and CEOJun 29Option Exercise39.0910,000390,92534,195,300Jun 29 07:38 PM
BLOCK KEITHPres., Vice Chairman and COOJun 29Sale86.7710,000867,6710Jun 29 07:34 PM
Benioff MarcChairman of the Board and CEOJun 29Sale86.5310,000865,27634,185,300Jun 29 07:38 PM
Roos John VictorDirectorJun 29Sale87.6522819,98416,816Jun 29 07:41 PM
Benioff MarcChairman of the Board and CEOJun 28Option Exercise39.0910,000390,92534,195,300Jun 28 08:18 PM
Robbins Cynthia G.EVP, Global Employee SuccessJun 28Sale87.392,000174,772477Jun 28 08:22 PM
Martinez MariaPres., Sales & Cust. SuccessJun 28Sale87.4013,7001,197,38920,907Jun 28 08:14 PM
Benioff MarcChairman of the Board and CEOJun 28Sale87.7710,000877,68434,185,300Jun 28 08:18 PM
Harris ParkerCo-FounderJun 27Option Exercise39.098,027313,79549,913Jun 27 08:43 PM
BLOCK KEITHPres., Vice Chairman and COOJun 27Option Exercise37.9510,000379,50010,000Jun 27 08:45 PM
Benioff MarcChairman of the Board and CEOJun 27Option Exercise39.0910,000390,92534,195,300Jun 28 08:18 PM
Harris ParkerCo-FounderJun 27Sale88.068,027706,89041,886Jun 27 08:43 PM
BLOCK KEITHPres., Vice Chairman and COOJun 27Sale87.6410,000876,3960Jun 27 08:45 PM
Benioff MarcChairman of the Board and CEOJun 27Sale88.0610,000880,64734,185,300Jun 28 08:18 PM
Hawkins Mark JChief Financial OfficerJun 26Option Exercise59.648,624514,33522,584Jun 26 06:39 PM
Benioff MarcChairman of the Board and CEOJun 26Option Exercise39.0910,000390,92534,195,300Jun 26 06:43 PM
Hawkins Mark JChief Financial OfficerJun 26Sale89.178,624769,00113,960Jun 26 06:39 PM
Benioff MarcChairman of the Board and CEOJun 26Sale88.3810,000883,75434,185,300Jun 26 06:43 PM
Benioff MarcChairman of the Board and CEOJun 23Option Exercise39.0910,000390,92534,195,300Jun 26 06:43 PM
Benioff MarcChairman of the Board and CEOJun 23Sale88.4410,000884,39334,185,300Jun 26 06:43 PM
Benioff MarcChairman of the Board and CEOJun 22Option Exercise39.0910,000390,92534,195,300Jun 22 08:08 PM
BLOCK KEITHPres., Vice Chairman and COOJun 22Option Exercise37.9510,000379,50010,000Jun 22 08:19 PM
Benioff MarcChairman of the Board and CEOJun 22Sale88.1810,000881,80034,185,300Jun 22 08:08 PM
BLOCK KEITHPres., Vice Chairman and COOJun 22Sale87.7810,000877,7730Jun 22 08:19 PM
Roos John VictorDirectorJun 22Sale88.0322820,07117,044Jun 22 08:03 PM
Benioff MarcChairman of the Board and CEOJun 21Option Exercise39.0910,000390,92534,195,300Jun 21 07:44 PM
Benioff MarcChairman of the Board and CEOJun 21Sale87.0610,000870,55234,185,300Jun 21 07:44 PM
Harris ParkerCo-FounderJun 20Option Exercise39.098,027313,79549,913Jun 21 07:25 PM
Benioff MarcChairman of the Board and CEOJun 20Option Exercise39.0910,000390,92534,195,300Jun 21 07:44 PM
BLOCK KEITHPres., Vice Chairman and COOJun 20Option Exercise37.9510,000379,50010,000Jun 21 07:50 PM
Harris ParkerCo-FounderJun 20Sale87.278,027700,52441,886Jun 21 07:25 PM
Benioff MarcChairman of the Board and CEOJun 20Sale87.2810,000872,75034,185,300Jun 21 07:44 PM
BLOCK KEITHPres., Vice Chairman and COOJun 20Sale87.2910,000872,8860Jun 21 07:50 PM
Benioff MarcChairman of the Board and CEOJun 19Option Exercise39.0910,000390,92534,195,300Jun 19 08:14 PM
Benioff MarcChairman of the Board and CEOJun 19Sale87.3910,000873,86734,185,300Jun 19 08:14 PM
Benioff MarcChairman of the Board and CEOJun 16Option Exercise39.0910,000390,92534,195,300Jun 19 08:14 PM
Benioff MarcChairman of the Board and CEOJun 16Sale86.2310,000862,29534,185,300Jun 19 08:14 PM
Benioff MarcChairman of the Board and CEOJun 15Option Exercise39.0910,000390,92534,195,300Jun 15 07:10 PM
BLOCK KEITHPres., Vice Chairman and COOJun 15Option Exercise37.9510,000379,50010,000Jun 15 07:29 PM
Benioff MarcChairman of the Board and CEOJun 15Sale85.7310,000857,33734,185,300Jun 15 07:10 PM
Roos John VictorDirectorJun 15Sale85.9922819,60617,272Jun 15 07:14 PM
Conway CraigDirectorJun 15Sale85.991,00085,9909,602Jun 15 07:21 PM
BLOCK KEITHPres., Vice Chairman and COOJun 15Sale85.5210,000855,2210Jun 15 07:29 PM
Benioff MarcChairman of the Board and CEOJun 14Option Exercise39.0910,000390,92534,195,300Jun 14 07:51 PM
Benioff MarcChairman of the Board and CEOJun 14Sale87.2910,000872,93734,185,300Jun 14 07:51 PM
Benioff MarcChairman of the Board and CEOJun 13Option Exercise39.0910,000390,92534,195,300Jun 13 07:50 PM
BLOCK KEITHPres., Vice Chairman and COOJun 13Option Exercise37.9510,000379,50010,000Jun 13 07:55 PM
Harris ParkerCo-FounderJun 13Option Exercise39.098,027313,79549,913Jun 13 08:00 PM
Benioff MarcChairman of the Board and CEOJun 13Sale87.3410,000873,36534,185,300Jun 13 07:50 PM
BLOCK KEITHPres., Vice Chairman and COOJun 13Sale87.8710,000878,6710Jun 13 07:55 PM
Harris ParkerCo-FounderJun 13Sale87.318,027700,85041,886Jun 13 08:00 PM
Benioff MarcChairman of the Board and CEOJun 12Option Exercise39.0910,000390,92534,195,300Jun 12 07:46 PM
Benioff MarcChairman of the Board and CEOJun 12Sale85.8510,000858,46634,185,300Jun 12 07:46 PM
Benioff MarcChairman of the Board and CEOJun 09Option Exercise39.0910,000390,92534,195,300Jun 12 07:46 PM
Benioff MarcChairman of the Board and CEOJun 09Sale88.7410,000887,39434,185,300Jun 12 07:46 PM
Benioff MarcChairman of the Board and CEOJun 08Option Exercise39.0910,000390,92534,195,300Jun 08 06:21 PM
BLOCK KEITHPres., Vice Chairman and COOJun 08Option Exercise37.9510,000379,50010,000Jun 08 06:24 PM
Benioff MarcChairman of the Board and CEOJun 08Sale91.0210,000910,21934,185,300Jun 08 06:21 PM
Roos John VictorDirectorJun 08Sale91.3922820,83717,500Jun 08 06:17 PM
BLOCK KEITHPres., Vice Chairman and COOJun 08Sale91.1610,000911,6160Jun 08 06:24 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-10.57 Insider Own0.20% Shs Outstand333.52M Perf Week2.08%
Market Cap83.70B Forward P/E14.01 EPS next Y17.92 Insider Trans-9.73% Shs Float333.52M Perf Month2.69%
Income-3688.70M PEG- EPS next Q3.92 Inst Own87.80% Short Float2.16% Perf Quarter6.19%
Sales14.74B P/S5.68 EPS this Y63.30% Inst Trans-0.09% Short Ratio3.26 Perf Half Y17.09%
Book/sh209.66 P/B1.20 EPS next Y11.39% ROA8.90% Target Price272.44 Perf Year1.26%
Cash/sh26.84 P/C9.35 EPS next 5Y13.10% ROE15.90% 52W Range184.50 - 261.27 Perf YTD19.50%
Dividend2.80 P/FCF- EPS past 5Y-28.70% ROI0.10% 52W High-3.94% Beta1.16
Dividend %1.12% Quick Ratio1.20 Sales past 5Y26.00% Gross Margin87.60% 52W Low36.03% ATR3.47
Employees16700 Current Ratio1.30 Sales Q/Q5.10% Oper. Margin-17.40% RSI (14)71.19 Volatility1.30% 1.37%
OptionableYes Debt/Eq0.45 EPS Q/Q- Profit Margin80.50% Rel Volume1.13 Prev Close249.07
ShortableYes LT Debt/Eq0.37 EarningsAug 03 BMO Payout2.40% Avg Volume2.21M Price250.97
Recom2.10 SMA202.43% SMA506.81% SMA20010.95% Volume2,509,861 Change0.76%
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Jul-22-17 10:00AM  Trump Could Still Unleash an Attack on Amazon Real Soon, Doug Kass Says TheStreet.com
Jul-17-17 11:30AM  Valeant Unloads Yet Another Unit Barrons.com
10:37AM  Inside Allergans International Business Market Realist
09:06AM  How Allergans US General Medicines Segment Performed Market Realist
07:37AM  How Allergans US Specialized Therapeutics Segment Performed Market Realist
Jul-14-17 10:37AM  Behind Allergans Business Segments and Revenues Market Realist
09:09AM  Understanding Allergans Revenue Stream for 2017 Market Realist
07:40AM  What Allergans Valuation as of July 13 Tells Us Market Realist
Jul-13-17 06:59PM  Cramer: Mea culpa! This stock's action is why I say small... CNBC Videos
05:33PM  Inside Allergans Developments in 2Q17 Market Realist
09:00AM  Allergan Lends Support to Broaden Uterine Fibroid Awareness Month PR Newswire
08:00AM  Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab) PR Newswire
Jul-11-17 04:29PM  Allergan Reports Positive New Data on Irritable Bowl Drug Zacks
03:12PM  As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals TheStreet.com
08:07AM  See America Furthers The Fight Against Preventable Blindness With #EyePic Campaign PR Newswire
07:36AM  A Look at Allergans Performance in 2Q17 Market Realist
Jul-10-17 10:30AM  Allergan Reports New Data Reinforcing the Effectiveness of Viberzi® (Eluxadoline) to Treat the Symptoms Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D), Abdominal Pain and Diarrhea PR Newswire
Jul-07-17 04:30PM  Allergan, Celgene Offer Solid Biotech Value TheStreet.com
04:19PM  AGN NOTICE: Rosen Law Firm Reminds Allergan, Inc. Investors of Important Deadline in Class Action Business Wire
03:51PM  US Pharmaceuticals: Mergers and Acquisitions in 2Q17 Market Realist
01:30PM  Allergan, Celgene Offer Solid Biotech Value TheStreet.com
10:05AM  UK Supreme Court rules in Eli Lilly's favor in drug dispute Associated Press
10:02AM  UK Supreme Court Rules in Lilly's Favor: Actavis Infringed on European Vitamins Patents TheStreet.com
07:33AM  Eli Lilly Wins Cancer Drug Patent Case at U.K. Supreme Court Bloomberg
Jul-05-17 07:14PM  10 Attractively Valued Stocks With Competitive Edge Forbes
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan, Inc. (AGN) & Lead Plaintiff Deadline: August 29, 2017 PR Newswire
Jul-03-17 11:55AM  Long-Term Performance of Hedge Funds Popular Picks Insider Monkey
10:14AM  Finding Value in Biotech? Barrons.com
07:30AM  Allergan to Report Second Quarter 2017 Earnings and Host Conference Call and Webcast PR Newswire
Jul-01-17 01:43PM  Looking At The Long-Term Performance of Hedge Funds Popular Picks from 2015 Insider Monkey
Jun-30-17 09:03PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. Business Wire
05:21PM  Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing TheStreet.com
05:18PM  [$$] Oklahoma Sues Opioid Painkiller Makers The Wall Street Journal
03:21PM  Oklahoma sues opioid drugmakers; New Hampshire presses epidemic probe Reuters
03:15PM  Securities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Allergan, Inc. During the Period February 25, 2014 Through April 21, 2014, Inclusive Business Wire
Jun-29-17 04:21PM  Could This Biotech Be Headed For A Deal After CEO Takes Reins? Investor's Business Daily
10:25AM  Sarepta Appoints Ex-Allergan Executive as CEO and President Zacks
10:12AM  Sarepta: A New CEO Goes a Long Way? Barrons.com
Jun-28-17 06:37PM  [$$] Sarepta Taps Chase Pharmaceuticals Chief as Next CEO The Wall Street Journal
05:14PM  Sarepta appoints former Allergan executive Douglas Ingram as CEO Reuters
07:00AM  Healthcare: ACA Repeal Efforts Unlikely to Yield Major Legislative Changes Morningstar
Jun-27-17 02:02PM  Valeant: Out of the Frying Pan, Into the Fire Barrons.com
09:51AM  Bill Ackman's Big Triumph Becomes His Big Problem Bloomberg
08:00AM  Allergan Introduces REFRESH OPTIVE® MEGA-3 Enhanced with Flaxseed Oil, Latest Innovation in the REFRESH® Portfolio PR Newswire
Jun-26-17 07:54PM  Dillard's Is One of the Best Long-Term Investments in Retail, Doug Kass Says TheStreet.com
02:17PM  Valeant Pharma: A Debt Swap? Barrons.com
09:15AM  Allergan Continues to Focus on Acquisitions and Branded Unit Zacks
Jun-23-17 01:32PM  Top Stock Reports for Oracle, Allergan & Abbott Zacks
Jun-21-17 02:23PM  Todd Hagopian's Top 2 Mental Health Biotech Stocks Forbes
Jun-20-17 07:01PM  Cramer: If There's No Reason for a Rally, Then Something's Wrong TheStreet.com
07:36AM  Key Updates on Eli Lillys Jardiance Market Realist
07:11AM  Novartis eye drug works with fewer injections than rivals Reuters
Jun-19-17 02:39PM  Allergan Is Putting the Bull Back in Charge TheStreet.com
01:47PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Isnt Healed by Paulsons Presence InvestorPlace
Jun-18-17 02:03PM  Could Legalized Marijuana Be Making Big Pharma Nervous? Motley Fool
Jun-15-17 03:42PM  5 Things Allergan's Management Just Said That You Need to Know Motley Fool
01:38PM  Allergan CEO on the battle over drug pricing CNBC Videos
08:13AM  Allergan Plc breached its 50 day moving average in a Bullish Manner : AGN-US : June 15, 2017 Capital Cube
Jun-11-17 02:27PM  Opioid Stocks Feel the Pressure of FDA Measures Investopedia
Jun-09-17 12:02PM  New migraine drugs have promise and a $8,500 price tag MarketWatch
Jun-08-17 12:54PM  Valeant Pharmaceuticals: Bigger is Better Barrons.com
10:05AM  Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit Zacks
Jun-07-17 10:54AM  Alkermes Gets FDA Nod for Two Month Dose of Aristada Zacks
09:00AM  Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab PR Newswire
08:43AM  Allergan to buy medical device company and breast surgery funnel-maker Keller Medical Inc. MarketWatch
08:30AM  Allergan to Acquire Keller Medical, Inc., Adding Keller Funnel® to Company's Leading Plastic Surgery Portfolio PR Newswire
07:31AM  Allergan to Present New Data on Chronic Migraine at the American Headache Society Meeting in Boston PR Newswire
Jun-05-17 02:01PM  Goldman Reveals Top Stocks Owned By Hedge Funds This Year Investopedia
09:01AM  Is Ironwood's Growth About to Slow? Motley Fool
08:15AM  Featured Company News - Mylan Launches Two New Generic Drugs: Generic Reclast® Injection and Generic Azilect® Tablets Accesswire
Jun-02-17 08:00AM  Allergan to Present at the Goldman Sachs Global Healthcare Conference PR Newswire
Jun-01-17 01:06AM  PRESS DIGEST - Wall Street Journal - June 1 Reuters
May-31-17 03:08PM  Ohio attorney general sues 5 drugmakers over opiate crisis Associated Press
02:43PM  [$$] Ohio sues drugmakers over US opioid addiction crisis Financial Times
02:33PM  Ohio Going After Drug Makers for Fueling Opioid Crisis TheStreet.com
01:33PM  Leon Cooperman Bets On These 19 Stocks Forbes
12:10PM  Johnson and Johnson, other drug companies accused of viol... CNBC Videos
08:00AM  Allergan to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans PR Newswire
May-30-17 12:18PM  Key Moves by Billionaire David Tepper's Appaloosa Mgmt in Q1: 13F Filings Investopedia
12:13PM  Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1 Investopedia
May-26-17 07:00AM  Allergan Announces Closing of Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
May-25-17 02:13PM  Aerie's Ophthalmic Candidate Positive in Registration Trial Zacks
02:01PM  TrumpCare isn't moving health care stocks because it won't pass: NYSE trader Yahoo Finance Video
07:55AM  Getting Struck Twice: Acquisitions & Spinouts In Biotech Forbes
May-24-17 04:30PM  Allergan Announces Pricing of Tender Offers by Certain Subsidiaries PR Newswire
11:19AM  Shark Bites: Focus on the 'Little Picture' TheStreet.com
08:00AM  Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries PR Newswire
May-23-17 06:09PM  Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE (Oxymetazoline HCL) Cream, 1% PR Newswire
05:30PM  Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
03:01PM  The biggest CEO pay raises and pay cuts of 2016 Associated Press
02:33PM  The biggest CEO pay raises and pay cuts of 2016 Associated Press
01:26PM  Has Allergan's Pullback Run Its Course? TheStreet.com
10:51AM  Allergan Funding SCS -- Moody's assigns Baa3 to Allergan's euro notes; stable outlook Moody's
06:00AM  These Big Drug Stocks May Cure the Trump Blues Investopedia
03:53AM  Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing Debt PR Newswire
May-22-17 08:27AM  3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter Motley Fool
05:28AM  European stocks edge higher as U.S. political commotion subsides MarketWatch
May-19-17 01:33PM  Valeant Pharmaceuticals: IntriguedReally? Barrons.com
09:48AM  Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA Zacks
May-17-17 10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E51.95 EPS (ttm)2.88 Insider Own0.10% Shs Outstand494.37M Perf Week2.30%
Market Cap73.92B Forward P/E29.35 EPS next Y5.10 Insider Trans-52.48% Shs Float491.77M Perf Month3.66%
Income1.44B PEG1.90 EPS next Q1.01 Inst Own89.90% Short Float0.99% Perf Quarter13.69%
Sales6.53B P/S11.33 EPS this Y86.70% Inst Trans0.06% Short Ratio1.92 Perf Half Y35.06%
Book/sh15.79 P/B9.47 EPS next Y25.43% ROA11.20% Target Price158.70 Perf Year55.20%
Cash/sh9.99 P/C14.97 EPS next 5Y27.40% ROE19.20% 52W Range95.42 - 150.10 Perf YTD45.24%
Dividend- P/FCF30.82 EPS past 5Y7.00% ROI13.20% 52W High-0.39% Beta1.00
Dividend %- Quick Ratio2.00 Sales past 5Y6.80% Gross Margin86.30% 52W Low56.70% ATR2.45
Employees15706 Current Ratio2.00 Sales Q/Q26.70% Oper. Margin27.80% RSI (14)66.61 Volatility1.22% 1.62%
OptionableYes Debt/Eq0.24 EPS Q/Q54.70% Profit Margin22.10% Rel Volume0.72 Prev Close149.94
ShortableYes LT Debt/Eq0.24 EarningsJun 20 AMC Payout0.00% Avg Volume2.53M Price149.52
Recom1.90 SMA203.75% SMA505.71% SMA20022.85% Volume1,819,520 Change-0.28%
Jun-21-17Reiterated BMO Capital Markets Outperform $160 → $165
Jun-12-17Downgrade Pivotal Research Group Hold → Sell $109 → $112
Jun-09-17Reiterated BMO Capital Markets Outperform $140 → $160
May-25-17Reiterated RBC Capital Mkts Outperform $135 → $157
Apr-13-17Initiated Guggenheim Buy
Apr-12-17Initiated Stifel Buy $150
Mar-24-17Upgrade Credit Suisse Neutral → Outperform
Mar-17-17Upgrade Wunderlich Hold → Buy
Mar-17-17Reiterated RBC Capital Mkts Outperform $130 → $135
Mar-17-17Reiterated Pivotal Research Group Hold $104 → $109
Mar-17-17Reiterated BMO Capital Markets Outperform $125 → $140
Feb-28-17Resumed Robert W. Baird Outperform $125 → $130
Feb-08-17Reiterated RBC Capital Mkts Outperform $115 → $125
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $136 → $104
Jan-11-17Initiated Wells Fargo Market Perform
Jan-05-17Initiated BMO Capital Markets Outperform $125
Nov-03-16Reiterated Wunderlich Hold $99 → $115
Sep-21-16Reiterated RBC Capital Mkts Outperform $115 → $116
Sep-21-16Reiterated Pivotal Research Group Buy $124 → $125
Jul-26-16Initiated Piper Jaffray Overweight $125
Jul-21-17 09:29PM  Microsoft's Surging Stock May Be Unstoppable TheStreet.com
Jul-20-17 08:13PM  Microsoft Office 365 Just Hit a Big Milestone Fortune
07:00PM  Cramer's lightning round: Owning this software stock is a... CNBC Videos
06:49PM  Cramer's lightning round: Owning this software stock is a high-quality problem CNBC
Jul-19-17 10:10AM  ADTRAN (ADTN) Tops Earnings and Revenue Estimates in Q2 Zacks
07:49AM  3 Reasons Alcoa Is No Longer The Curtain-Raising Event Of Earnings Season Benzinga
Jul-18-17 06:00PM  3 Growth Stocks for the Long Term Motley Fool
Jul-17-17 09:30AM  The Zacks Analyst Blog Highlights: Red Hat, Verint Systems, Exa, Progress Software and Adobe Systems Zacks
Jul-13-17 06:19PM  Adobe to add fourth tower to San Jose's skyline with major expansion American City Business Journals
06:03PM  MainStay Mutual Fund Enjoying Big Rally, With Stocks Like Alibaba Investor's Business Daily
03:23PM  ETFs with exposure to Adobe Systems, Inc. : July 13, 2017 Capital Cube
01:43PM  3 Cloud Stocks to Buy Right Now Zacks
Jul-12-17 05:40PM  After-hours buzz: AMG, MNK & more CNBC
Jul-05-17 07:18PM  Cramer Remix: Dont roll your eyes at this massive market... CNBC Videos
06:40PM  Cramer uses tech's top 10 stocks to argue the sector is n... CNBC Videos
06:37PM  Cramer uses tech's top 10 stocks to argue the sector is not overvalued CNBC
03:16PM  20 college discounts you never knew existed Yahoo Finance
12:30PM  Be Careful, Adobe Is Shifting Sideways From Up TheStreet.com
10:31AM  3 Big Stock Charts for Wednesday: Alphabet Inc (GOOG), Amazon.com, Inc. (AMZN) and Adobe Systems Incorporated (ADBE) InvestorPlace
10:31AM  Adobe Is Shifting Sideways From Up TheStreet.com
Jul-04-17 10:06AM  Adobe Systems, Inc. breached its 50 day moving average in a Bearish Manner : ADBE-US : July 4, 2017 Capital Cube
Jul-03-17 02:45PM  ETFs with exposure to Adobe Systems, Inc. : July 3, 2017 Capital Cube
Jun-30-17 12:22PM  Adobe Systems Incorporated (ADBE) Stock Is In a Rare Dip Buy It! InvestorPlace
11:43AM  Adobe Systems, Inc. :ADBE-US: Earnings Analysis: Q2, 2017 By the Numbers : June 30, 2017 Capital Cube
08:15AM  Earnings Review and Free Research Report: Adobe Reported Another Quarter of Record Revenue and Operating Profit Accesswire
Jun-29-17 06:59PM  Adobe Wants to Track How People Use Siri, Alexa, and Other Digital Assistants Fortune
03:11PM  [$$] Funding Snapshot: Video Startup Make.TV Raises $8.5 Million The Wall Street Journal
09:00AM  Adobe Advances Voice-Driven Customer Experiences With Analytics Cloud Business Wire
Jun-28-17 08:55AM  Is Adobe (ADBE) a Great Growth Stock? Zacks
Jun-26-17 09:10AM  Is Adobe Likely to Gain from its Buyout of Mettle's SkyBox? Zacks
Jun-24-17 03:00PM  Adobe Blew Wall Street Away and Is Being Rewarded Accordingly -- Jim Cramer's Thoughts TheStreet.com
08:30AM  Apple's Siri Problem, and Nvidia and AMD's Cryptocurrency Boost -- TheStreet's 5 Top Tech Ideas TheStreet.com
Jun-23-17 08:49PM  Plunging Oil Drives Markets in Dog Days of Summer: Week in Review TheStreet.com
07:10PM  Cramers Exec Cut: These CEOs are ready to modernize Amer... CNBC Videos
10:40AM  Oracle Is Heading Even Higher Into the Clouds TheStreet.com
09:00AM  Media Alert: Adobe Analytics Shows Online Apparel Sales Putting Pressure on In-Store Sales Business Wire
08:39AM  Adobe Hit A New High, But Are Analysts Impressed? Benzinga
Jun-22-17 06:45PM  Adobe Creates Record Earnings: Its Head Is in the Clouds Motley Fool
04:12PM  Adobe Systems Stock Gets More Price-Target Hikes Post-Earnings Investor's Business Daily
02:56PM  Watch Cramer as a real-time cartoon, and why it made him ... CNBC Videos
10:57AM  Company News for June 22, 2017 Zacks
10:16AM  Stick With Adobe Systems Incorporated (ADBE) Stock as the Cloud Grows InvestorPlace
10:02AM  Watch Cramer as a real-time A.I. cartoon, and why it made him a believer in Adobe stock CNBC
09:11AM  Jim Cramer like you've never seen him before... CNBC Videos
06:32AM  Adobe: Cramer's Top Takeaways TheStreet.com
Jun-21-17 08:00PM  Dow and S&P 500 Dive Further From Records as Oil Price Rout Rages On TheStreet.com
06:59PM  Cramer Remix: These stocks are downright painful to own CNBC
06:26PM  Adobe CEO: Microsoft partnership will automate sales, marketing with AI CNBC
06:15PM  Adobe CEO: Microsoft partnership will automate sales, mar... CNBC Videos
06:00PM  Cramer finds where the real growth is in a split market CNBC Videos
05:48PM  Finding real growth in a split market CNBC Videos
05:10PM  What Happened in the Stock Market Today Motley Fool
05:10PM  Adobe, FedEx gain; Actuant and Whirlpool fall Associated Press
04:09PM  Boeing, Adobe, Red Hat Price Targets Hiked; Chevron Downgraded Investor's Business Daily
04:04PM  Adobe Stock Hits Record High On Beat-And-Raise Earnings Report Investor's Business Daily
02:05PM  Energy Sector Pressures the Dow and S&P 500 as Crude Selloff Steepens TheStreet.com
12:00PM  Adobe Continues to Drive 360 Video and VR Innovation with Acquisition of Mettles Skybox Tools for Editing and Visual Effects Business Wire
11:55AM  3 Big Stock Charts for Wednesday: HP Inc (HPQ), Adobe Systems Incorporated (ADBE) and Apple Inc. (AAPL) InvestorPlace
11:39AM  US STOCKS-Nasdaq boosted by biotechs; banks weigh on Dow, S&P Reuters
11:24AM  Adobe's Q2 Strength Keeps The Bull Thesis Intact Benzinga
11:11AM  Jim Cramer: Adobe Is Hitting at All Cylinders TheStreet.com
10:58AM  Why Adobe's Investors Are Dancing on Cloud 9 Investopedia
10:49AM  Adobe Upside Looks Limited Despite Solid Quarter Investopedia
10:43AM  S&P 500 and Nasdaq Higher, Crude Oil Jumps as Stockpiles Decline TheStreet.com
10:34AM  Catch the Adobe Systems Incorporated (ADBE) Stock Flying Knife InvestorPlace
10:10AM  Adobe (ADBE) Beats Earnings and Revenue Estimates in Q2 Zacks
10:04AM  San Jose City Council votes 10-1 to begin negotiations with Google for Diridon Station project American City Business Journals
10:04AM  Dont Touch Red Hat Inc (RHT) Stock After Its Q1 Bonanza InvestorPlace
09:55AM  Cramer's Stop Trading: Adobe growth CNBC Videos
09:47AM  Earnings Calendar, Analyst Estimates And Stocks To Watch Investor's Business Daily
09:45AM  Stocks Open Higher; 2 Software Makers Spike On Earnings Investor's Business Daily
09:38AM  Story Stocks from Briefing.com Briefing.com
08:58AM  U.S. stock-index futures point to lackluster open MarketWatch
08:54AM  3 Stocks to Watch on Wednesday: Carmax, Inc (KMX), Adobe Systems Incorporated (ADBE) and Sangamo Therapeutics Inc (SGMO) InvestorPlace
08:34AM  Morning Movers: La-Z-Boy Flies on Earnings; Chesapeake Energy Drops on Downgrade Barrons.com
08:25AM  Stock Futures Down Slightly Even as Crude Oil Turns Higher TheStreet.com
08:00AM  Adobe's Dominant Position in This One Market Keeps It a Wall Street Darling TheStreet.com
07:49AM  Early movers: TGT, FDX, JNJ, PYPL, TSLA, CVX, ADBE & more CNBC
06:47AM  5 Things You Must Know Before the Market Opens Wednesday TheStreet.com
01:24AM  Edited Transcript of ADBE earnings conference call or presentation 20-Jun-17 9:00pm GMT Thomson Reuters StreetEvents
Jun-20-17 09:26PM  Adobe beats Street 2Q forecasts Associated Press
09:05PM  Adobe's Creative Cloud Keeps Predictably Beating Expectations TheStreet.com
08:32PM  Adobe Systems Climbs to New Highs on Accelerated Growth Motley Fool
07:43PM  Adobe Up 4% on FYQ2 Beat, Higher Q3 View Barrons.com
06:50PM  President Trump Wants to Move Government to the Cloud TheStreet.com
06:45PM  Adobe's cloud push fuels profit beat, shares surge Reuters
05:36PM  After-hours buzz: ADBE, FDX, & more CNBC
05:23PM  4 Reasons To Buy Adobe Systems Before It Hits $200 Forbes
05:05PM  Adobe Crushes Wall Street's Q2 Estimates, Guides Higher Investor's Business Daily
04:21PM  Adobe Notches Beat Again With Sales Outlook on Cloud Demand Bloomberg
04:14PM  Adobe rises to record levels after beating earnings expectations MarketWatch
04:06PM  Jim Cramer -- Here's Your Game Plan for Adobe, FedEx Earnings TheStreet.com
04:05PM  Adobe Achieves Record Revenue Business Wire
03:41PM  How to Play Adobe Ahead of Earnings Bloomberg Video
12:32PM  Adobe Is Overbought TheStreet.com
11:13AM  Adobe Unveils Advertising Cloud TV Integrated with Analytics Zacks
10:33AM  Why Oracle Corporation (ORCL) Stock Is Looking as Sharp as Ever InvestorPlace
07:21AM  Tech Stocks Aren't Dead, They Are Alive Baby: Market Recon TheStreet.com
Jun-19-17 04:49PM  Adobe Systems Looks To Continue Winning Ways Investor's Business Daily
04:44PM  4 Hot Stocks, 1 Big ETF To Watch Tuesday: Investing Action Plan Investor's Business Daily
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, advertising and media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parasnis AbhayEVP & CTOJul 21Sale149.3812,5001,867,20512,623Jul 21 04:55 PM
Parasnis AbhayEVP & CTOJul 20Option Exercise0.0041,750046,908Jul 21 04:55 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJul 20Sale150.0010,0001,500,00065,083Jul 21 04:57 PM
GESCHKE CHARLES MDirectorJul 13Sale145.1625,0003,628,985172,024Jul 14 04:40 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 12Sale144.001,953281,23259,991Jul 14 04:17 PM
ROSENSWEIG DANIELDirectorJun 28Sale143.284,000573,1242,268Jun 30 04:40 PM
ROSENSWEIG DANIELDirectorJun 28Sale143.957,0001,007,6528,801Jun 30 04:40 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJun 23Sale145.005,000725,00074,812Jun 27 05:13 PM
WARNOCK JOHN EDirectorJun 22Sale144.0732,6004,696,796487,301Jun 23 04:08 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 14Sale139.292,233311,03561,944Jun 15 06:02 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 10Sale135.862,233303,37564,177May 11 06:27 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 12Sale129.962,233290,20166,410Apr 13 04:17 PM
Desmond LauraDirectorApr 11Option Exercise0.002,801023,852Apr 13 04:14 PM
GESCHKE CHARLES MDirectorApr 11Option Exercise0.002,8010172,024Apr 13 04:15 PM
ROSENSWEIG DANIELDirectorApr 11Option Exercise0.002,801015,801Apr 13 04:15 PM
BARNHOLT EDWARD WDirectorApr 11Option Exercise0.002,801035,925Apr 13 04:13 PM
BURGESS ROBERT KDirectorApr 11Option Exercise0.002,801039,925Apr 13 04:13 PM
CALDERONI FRANKDirectorApr 11Option Exercise0.002,801023,852Apr 13 04:14 PM
DALEY JAMES EDirectorApr 11Option Exercise0.002,801030,887Apr 13 04:14 PM
Banse AmyDirectorApr 11Option Exercise0.002,801030,592Apr 13 04:12 PM
LAMKIN BRYANEVP & GM, Digital MediaMar 31Sale130.3020,0002,605,95052,083Mar 31 07:29 PM
Lewnes AnnEVP, Chief Marketing OfficerMar 22Sale125.002,233279,12568,643Mar 24 04:05 PM
GESCHKE CHARLES MDirectorMar 20Sale125.9559,5507,500,060169,223Mar 21 04:25 PM
LAMKIN BRYANEVP & GM, Digital MediaMar 15Option Exercise0.0019,750082,388Mar 17 04:27 PM
GARRETT MARKEVP, CFO & Asst. SecretaryFeb 06Sale114.1245,1995,158,0864,339Feb 07 04:10 PM
BURGESS ROBERT KDirectorFeb 02Option Exercise42.6125,0001,065,25062,124Feb 03 04:11 PM
BURGESS ROBERT KDirectorFeb 02Sale113.1925,0002,829,71037,124Feb 03 04:11 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 27Sale113.0810,4401,180,54447,482Jan 27 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 25Sale113.7855,0006,257,92851,919Jan 26 04:14 PM
Rencher BradleyEVP & GM, Digital MarketingJan 25Sale113.9640,0004,558,27650,735Jan 26 04:14 PM
NARAYEN SHANTANUPresident and CEOJan 25Sale113.91173,70319,787,246299,243Jan 26 04:13 PM
NARAYEN SHANTANUPresident and CEOJan 24Option Exercise0.00363,2400549,812Jan 26 04:13 PM
Parasnis AbhayEVP & CTOJan 24Option Exercise0.008,16508,436Jan 26 04:13 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0056,036068,744Jan 26 04:12 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00103,587071,082Jan 26 04:12 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.0080,7200101,620Jan 26 04:14 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0013,748010,098Jan 26 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00113,7560131,387Jan 26 04:14 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0080,153078,016Jan 26 04:12 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0056,620080,588Jan 26 04:12 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0056,620089,524Jan 26 04:13 PM
DALEY JAMES EDirectorJan 20Option Exercise33.2310,000332,30038,086Jan 23 04:58 PM
DALEY JAMES EDirectorJan 20Sale110.0210,0001,100,20028,086Jan 23 04:58 PM
WARNOCK JOHN ECo-Chairman of the BoardJan 17Sale107.285,000536,405559,600Jan 17 04:14 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 09Sale108.5223,1002,506,775228,773Jan 09 06:24 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 06Sale108.131,348145,7600Jan 06 06:54 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 04Sale104.0348,1005,003,800251,873Jan 05 04:20 PM
WARNOCK JOHN ECo-Chairman of the BoardDec 19Sale105.416,000632,472565,600Dec 21 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceOct 10Sale110.0010,0001,100,00054,279Oct 11 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryOct 10Sale109.6413,3311,461,57930,993Oct 11 04:41 PM
WARNOCK JOHN ECo-Chairman of the BoardSep 27Sale106.995,000534,950571,600Sep 27 04:49 PM
ROSENSWEIG DANIELDirectorSep 26Sale107.4213,0001,396,4266,268Sep 27 04:47 PM
DALEY JAMES EDirectorSep 22Option Exercise33.236,276208,55134,362Sep 23 05:00 PM
DALEY JAMES EDirectorSep 22Sale108.006,276677,80828,086Sep 23 05:00 PM
GARRETT MARKEVP, CFO & Asst. SecretarySep 06Sale103.4726,8992,783,3120Sep 06 07:01 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 29Sale101.855,450555,08344,324Aug 29 06:11 PM
Lewnes AnnEVP, Chief Marketing OfficerAug 26Sale101.6813113,32042,968Aug 29 04:29 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500064,123Aug 24 04:08 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 17 04:31 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Option Exercise34.032,33579,46076,614Aug 11 04:05 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.0010,0001,000,00064,279Aug 11 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.002,335233,50074,279Aug 11 04:05 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 29Sale98.404,000393,60043,099Aug 01 04:09 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E88.28 EPS (ttm)1.86 Insider Own0.10% Shs Outstand299.17M Perf Week0.49%
Market Cap49.07B Forward P/E9.80 EPS next Y16.73 Insider Trans0.00% Shs Float299.17M Perf Month-3.94%
Income548.80M PEG6.79 EPS next Q3.53 Inst Own22.10% Short Float0.31% Perf Quarter-4.60%
Sales13.26B P/S3.70 EPS this Y-65.50% Inst Trans0.08% Short Ratio0.78 Perf Half Y1.43%
Book/sh98.66 P/B1.66 EPS next Y12.46% ROA0.40% Target Price238.75 Perf Year-15.21%
Cash/sh- P/C- EPS next 5Y13.00% ROE1.00% 52W Range158.54 - 209.22 Perf YTD-3.73%
Dividend0.91 P/FCF- EPS past 5Y-12.80% ROI2.10% 52W High-21.60% Beta1.60
Dividend %0.55% Quick Ratio0.50 Sales past 5Y22.30% Gross Margin63.10% 52W Low3.46% ATR3.32
Employees23906 Current Ratio1.00 Sales Q/Q109.00% Oper. Margin6.90% RSI (14)42.98 Volatility1.97% 1.72%
OptionableYes Debt/Eq0.76 EPS Q/Q-43.60% Profit Margin2.10% Rel Volume1.92 Prev Close160.22
ShortableYes LT Debt/Eq0.66 EarningsAug 03 BMO Payout0.00% Avg Volume1.19M Price164.03
Recom1.80 SMA20-1.51% SMA50-4.61% SMA200-6.13% Volume2,290,465 Change2.38%
Jun-16-17Initiated Cantor Fitzgerald Overweight $222
Jun-09-17Reiterated Jefferies Buy $239 → $216
Jun-01-17Downgrade Liberum Buy → Hold
May-26-17Downgrade Bernstein Outperform → Mkt Perform
May-19-17Downgrade HSBC Securities Hold → Reduce
Mar-09-17Initiated Liberum Buy
Dec-02-16Initiated Societe Generale Buy
Sep-26-16Downgrade HSBC Securities Buy → Hold
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Jul-20-17 11:08AM  New Strong Sell Stocks for July 20th Zacks
Jul-18-17 07:02AM  Shire plc : Notice of Results GlobeNewswire
07:02AM  Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody GlobeNewswire
Jul-16-17 08:18AM  [$$] Shire boss says share price at odds with drugs pipeline Financial Times
Jul-13-17 09:30AM  The Zacks Analyst Blog Highlights: Merck, Eli Lilly, Celgene, Gilead Sciences and Shire Zacks
08:13AM  5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings Zacks
Jul-12-17 06:01PM  A Cancer Breakthrough Near FDA Approval Has a Costly Side Effect Bloomberg
09:15AM  Analyst: Shire Shares Should Rebound, But Sustained Rally Unlikely Benzinga
Jul-11-17 08:39PM  Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run TheStreet.com
04:19PM  Alnylam (ALNY) Stock Down Despite Positive Hemophilia Data Zacks
Jul-10-17 09:47AM  Shire, Roche slug it out in billion-dollar haemophilia drug battle Reuters
Jul-07-17 09:42AM  Shire Completes NDA Filing for Hemophilia Drug with FDA Zacks
Jul-06-17 07:01AM  Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A GlobeNewswire
02:02AM  Shire plc : Additional Listing GlobeNewswire
Jul-05-17 08:03AM  3 Reasons Sizzling-Hot Bioverativ Stock Can Go Even Higher Motley Fool
Jul-03-17 08:32AM  Shire plc : Director/PDMR Shareholding GlobeNewswire
07:01AM  Shire plc : Total voting rights GlobeNewswire
Jun-26-17 09:30AM  The Zacks Analyst Blog Highlights: Novartis, Roche, Shire, Neos and Novo Nordisk Zacks
Jun-23-17 08:02AM  SHIRE TO PRESENT NEW DATA AT ISTH 2017 TO ADVANCE THE STANDARD OF CARE IN HEMOPHILIA GlobeNewswire
07:42AM  Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod Zacks
Jun-22-17 10:54AM  Shire (SHPG) Receives MAA Validation for Veyvondi by EMA Zacks
09:36AM  Biotech Movers: Shire, Bellicum, Organovo TheStreet.com
01:00AM  Shire Announces EMA Validation of Veyvondi Marketing Authorization Application for Treatment of Von Willebrand Disease PR Newswire
Jun-21-17 10:52AM  Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US Zacks
10:25AM  Shire wins FDA approval for new ADHD drug American City Business Journals
Jun-20-17 07:19PM  Shire's long-acting ADHD drug wins U.S. approval Reuters
06:48PM  Shire plc: U.S. FDA Approves Mydayis (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older PR Newswire
Jun-19-17 09:45AM  Could Shire PLC (SHPG) Be a Great Stock for Value Investors? Zacks
09:02AM  Do You Really Want to Love Your Medicines? Fortune
Jun-16-17 10:54AM  Valeant: Stop Looking in the Rearview Mirror! Barrons.com
Jun-14-17 06:00AM  10 High-Quality Foreign-Stock Bargains Morningstar
Jun-08-17 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Shire plc (SHPG) PR Newswire
Jun-07-17 03:53PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shire plc - SHPG PR Newswire
Jun-06-17 12:03PM  Down 24.6%, is BioCryst Pharmaceuticals Stock Now a Buy? Motley Fool
Jun-05-17 07:47AM  Key FDA Events to Watch Out for in Jun 2017 Zacks
May-30-17 12:13PM  Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1 Investopedia
May-25-17 03:06PM  Why BioCryst Pharmaceuticals Stock Caught Fire Today Motley Fool
07:00AM  Shire to Participate at the Jefferies Healthcare Conference PR Newswire
May-24-17 09:17AM  Ultragenyx Receives Priority Review for rhGUS from FDA Zacks
May-22-17 01:05PM  Shire and tiny Lexington biotech say hemophilia drug trial misses mark American City Business Journals
May-19-17 05:21PM  Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug Zacks
12:48PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
10:17AM  Company News for May 19, 2017 Zacks
08:15AM  Blog Coverage: Shire's Stock Price Jumped on Positive Results in Hereditary Angioedema Treatment Accesswire
07:43AM  Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More Zacks
01:00AM  Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology PR Newswire
May-18-17 05:27PM  Drugmaker Leads Industry Gains Thursday On Rare Disease Trial Investor's Business Daily
05:11PM  [$$] Biotech Investor Clarus Ventures Raising $880 Million Fund The Wall Street Journal
11:54AM  Shire's swelling disorder drug moves closer to U.S. approval Reuters
11:15AM  Shire gains $2B in market cap as rare disease drug aces late-stage trial American City Business Journals
09:00AM  The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis PR Newswire
07:18AM  Shire ADRs jump almost 7% premarket after positive trial of Angioedema treatment MarketWatch
07:00AM  Shire's Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial PR Newswire
May-16-17 04:55PM  [$$] Health-Care Investor Agent Capital Seeks $100 Million Fund The Wall Street Journal
07:00AM  Shire Continues 20-Year Commitment to ADHD with New Research at 2017 Annual Meeting of American Psychiatric Association PR Newswire
May-15-17 04:37PM  ETFs with exposure to Shire Plc : May 15, 2017 Capital Cube
May-05-17 04:33PM  ETFs with exposure to Shire Plc : May 5, 2017 Capital Cube
10:37AM  Keryx (KERX) Q1 Loss Wider than Expected, Revenues Beat Zacks
May-04-17 11:10AM  Shire Plc :SHPG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube
May-03-17 11:17AM  Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View Zacks
10:32AM  Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat Zacks
May-02-17 09:23AM  [$$] Shire Profit Pressured by Baxalta Takeover Costs The Wall Street Journal
09:10AM  Durham CEO on deal with Shire valued at up to $535M American City Business Journals
08:42AM  Shire Stock Lifted By First-Quarter Earnings Beat TheStreet.com
07:27AM  Shire tops Street 1Q forecasts Associated Press
07:00AM  Shire Delivers Strong Q1 2017 Revenue Growth While Advancing Late-stage Pipeline PR Newswire
May-01-17 07:00AM  Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications PR Newswire
Apr-26-17 01:00AM  Shire Granted EU Conditional Marketing Authorisation for Natpar (Parathyroid Hormone) for the Treatment of Patients with Chronic Hypoparathyroidism PR Newswire
Apr-25-17 03:48PM  ETFs with exposure to Shire Plc : April 25, 2017 Capital Cube
08:15AM  Blog Coverage Eli Lilly's Breast Cancer Drug Achieved its Primary Endpoint in Late Stage Trial Accesswire
07:00AM  Shire to Participate at the Deutsche Bank 42nd Annual Health Care Conference PR Newswire
Apr-24-17 01:00AM  Shire Launches #PIPostsThanks Social Campaign to Raise Awareness of Primary Immunodeficiency (PI) PR Newswire
Apr-17-17 01:00AM  Shire plc: Data Show A Bleeding Episode Occurs Every Three to 15 Seconds in People Living With Hemophilia Worldwide PR Newswire
Apr-10-17 07:00AM  PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases Business Wire
Apr-06-17 08:22AM  Novartis Licenses ECF843 Eye Drops From Lubris Investopedia
Apr-04-17 11:12AM  Shire Plc : SHPG-US: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 4, 2017 Capital Cube
Apr-03-17 01:48PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-30-17 04:41AM  INTUNIV® (Guanfacine Hydrochloride Prolonged Release), a Non-stimulant for the Treatment of ADHD, Receives Approval in Japan PR Newswire
Mar-28-17 04:50PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Mar-27-17 01:32PM  Shire: Can It Pay Down Debt? Barrons.com
Mar-23-17 05:03PM  Shire (SHPG) Rare Disease Drug Gets Fast Track Designation Zacks
Mar-22-17 10:27AM  Shire hTTP Drug Secures Fast Track Designation Investopedia
07:00AM  Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura PR Newswire
Mar-21-17 09:55AM  Is Shire Stock a Good Choice for Value Investors Now? Zacks
Mar-16-17 07:14PM  Shire's (SHPG) Cinryze Label Expanded for Pediatric Use Zacks
10:40AM  Shires Cinryze Drug Gets EU Label Expansion Investopedia
02:00AM  Shire Receives European Approval for Label Extension of CINRYZE®(C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE PR Newswire
Mar-13-17 02:50PM  Whats that thing on top of the Sanofi-Genzyme building anyway? at bizjournals.com
02:31PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Mar-10-17 04:25PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
01:20PM  Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs
Mar-09-17 08:49AM  Coverage initiated on Shire plc by Liberum
Mar-07-17 12:48PM  European Stocks Mixed as Frankfurt Rises, Paris Falls
Mar-06-17 01:55PM  CUVITRU Data Demonstrate Improved Treatment Satisfaction Relative to Patients' Previous Immunoglobulin Therapy PR Newswire
Mar-03-17 12:34PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Mar-02-17 05:08PM  Merrimack (MACK) Q4 Loss Lower than Expected, Revenues Top
12:34PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
12:12PM  These 3 Big Pharma Stocks Are Exceptionally Cheap at Motley Fool
Mar-01-17 05:02PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Shire to Participate at the Cowen 37th Annual Healthcare Conference PR Newswire
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.
DAL Delta Air Lines, Inc. daily Stock Chart
DAL [NYSE]
Delta Air Lines, Inc.
IndexS&P 500 P/E10.37 EPS (ttm)5.04 Insider Own0.20% Shs Outstand727.63M Perf Week-5.21%
Market Cap38.03B Forward P/E8.55 EPS next Y6.11 Insider Trans-13.63% Shs Float727.63M Perf Month-0.02%
Income3.71B PEG1.83 EPS next Q1.80 Inst Own88.40% Short Float2.22% Perf Quarter14.78%
Sales39.88B P/S0.95 EPS this Y2.90% Inst Trans0.00%